{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:40:02Z","timestamp":1759156802148,"version":"3.44.0"},"reference-count":303,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT9425-23-1-0239","HT9425-23-1-0239"],"award-info":[{"award-number":["HT9425-23-1-0239","HT9425-23-1-0239"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014804","name":"Neurofibromatosis Therapeutic Acceleration Program","doi-asserted-by":"publisher","award":["210112"],"award-info":[{"award-number":["210112"]}],"id":[{"id":"10.13039\/100014804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K12HD076244"],"award-info":[{"award-number":["K12HD076244"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR210085"],"award-info":[{"award-number":["RR210085"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016618","name":"Gilbert Family Foundation","doi-asserted-by":"publisher","award":["622030"],"award-info":[{"award-number":["622030"]}],"id":[{"id":"10.13039\/100016618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012394","name":"Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012287","name":"Andrew Sabin Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02119-4","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:42:14Z","timestamp":1759153334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1)"],"prefix":"10.1186","volume":"13","author":[{"given":"Benjamin E","family":"Aghoghovwia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-En","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabiha","family":"Bano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandini","family":"Shyamala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alesandra","family":"Echeandia Marrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khushboo","family":"Irshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Sharafaldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M","family":"Brossier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"2119_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","volume":"62","author":"D Viskochil","year":"1990","unstructured":"Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK et al (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187\u2013192","journal-title":"Cell"},{"key":"2119_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","volume":"62","author":"RM Cawthon","year":"1990","unstructured":"Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J et al (1990) A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62:193\u2013201","journal-title":"Cell"},{"key":"2119_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1126\/science.2134734","volume":"249","author":"MR Wallace","year":"1990","unstructured":"Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM et al (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249:181\u2013186","journal-title":"Science"},{"key":"2119_CR4","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","volume":"3","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (2017) Neurofibromatosis type 1. Nat Rev Primer 3:17004","journal-title":"Nat Rev Primer"},{"key":"2119_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/jmg.26.11.704","volume":"26","author":"SM Huson","year":"1989","unstructured":"Huson SM, Compston DA, Clark P, Harper PS (1989) A genetic study of von Recklinghausen neurofibromatosis in South East wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 26:704\u2013711","journal-title":"J Med Genet"},{"key":"2119_CR6","doi-asserted-by":"crossref","unstructured":"Gutmann DH, Anastasaki C, Gupta A, Hou Y, Morris SM, Payne JM et al (2025) Cognition and behavior in neurofibromatosis type 1: report and perspective from the cognition and behavior in NF1 (CABIN) task force. Genes Dev 2;39(9\u201310):541\u2013554","DOI":"10.1101\/gad.352629.125"},{"key":"2119_CR7","first-page":"185","volume":"6","author":"CW Koth","year":"2000","unstructured":"Koth CW, Cutting LE, Denckla MB (2000) The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder. Child Neuropsychol J Norm Abnorm Dev Child Adolesc 6:185\u2013194","journal-title":"Child Neuropsychol J Norm Abnorm Dev Child Adolesc"},{"key":"2119_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/1087054707299398","volume":"11","author":"FX Coud\u00e9","year":"2007","unstructured":"Coud\u00e9 FX, Mignot C, Lyonnet S, Munnich A (2007) Early grade repetition and inattention associated with neurofibromatosis type 1. J Atten Disord 11:101\u2013105","journal-title":"J Atten Disord"},{"key":"2119_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/0883073812439435","volume":"28","author":"JC Isenberg","year":"2013","unstructured":"Isenberg JC, Templer A, Gao F, Titus JB, Gutmann DH (2013) Attention skills in children with neurofibromatosis type 1. J Child Neurol 28:45\u201349","journal-title":"J Child Neurol"},{"key":"2119_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.nicl.2017.02.014","volume":"14","author":"A Bluschke","year":"2017","unstructured":"Bluschke A, von der Hagen M, Papenhagen K, Roessner V, Beste C (2017) Conflict processing in juvenile patients with neurofibromatosis type 1 (NF1) and healthy controls \u2013 Two pathways to success. NeuroImage Clin 14:499\u2013505","journal-title":"NeuroImage Clin"},{"key":"2119_CR11","doi-asserted-by":"publisher","first-page":"43929","DOI":"10.1038\/srep43929","volume":"7","author":"A Bluschke","year":"2017","unstructured":"Bluschke A, von der Hagen M, Papenhagen K, Roessner V, Beste C (2017) Response Inhibition in attention deficit disorder and neurofibromatosis type 1 \u2013 clinically similar, neurophysiologically different. Sci Rep 7:43929","journal-title":"Sci Rep"},{"key":"2119_CR12","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1177\/1087054719894384","volume":"25","author":"JM Payne","year":"2021","unstructured":"Payne JM, Haebich KM, MacKenzie R, Walsh KS, Hearps SJC, Coghill D et al (2021) Cognition, ADHD symptoms, and functional impairment in children and adolescents with neurofibromatosis type 1. J Atten Disord 25:1177\u20131186","journal-title":"J Atten Disord"},{"key":"2119_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jaac.2024.09.011","volume":"64","author":"Y Hou","year":"2025","unstructured":"Hou Y, Yu L, Liu D, Wilson-Lemoine E, Wu X, Moreira JP et al (2025) Systematic review and Meta-Analysis: Attention-Deficit\/Hyperactivity disorder symptoms in children with neurofibromatosis type 1. J Am Acad Child Adolesc Psychiatry 64:447\u2013462","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2119_CR14","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/ajmg.a.35915","volume":"161A","author":"GD Leschziner","year":"2013","unstructured":"Leschziner GD, Golding JF, Ferner RE (2013) Sleep disturbance as part of the neurofibromatosis type 1 phenotype in adults. Am J Med Genet A 161A:1319\u20131322","journal-title":"Am J Med Genet A"},{"key":"2119_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/cge.12551","volume":"88","author":"JS Cohen","year":"2015","unstructured":"Cohen JS, Levy HP, Sloan J, Dariotis J, Biesecker BB (2015) Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life. Clin Genet 88:425\u2013430","journal-title":"Clin Genet"},{"key":"2119_CR16","doi-asserted-by":"publisher","first-page":"e1642","DOI":"10.1542\/peds.2013-1868","volume":"132","author":"S Garg","year":"2013","unstructured":"Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans DG et al (2013) Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics 132:e1642\u20131648","journal-title":"Pediatrics"},{"key":"2119_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/dmcn.12038","volume":"55","author":"KS Walsh","year":"2013","unstructured":"Walsh KS, V\u00e9lez JI, Kardel PG, Imas DM, Muenke M, Packer RJ et al (2013) Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Dev Med Child Neurol 55:131\u2013138","journal-title":"Dev Med Child Neurol"},{"key":"2119_CR18","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamapsychiatry.2016.2600","volume":"73","author":"SM Morris","year":"2016","unstructured":"Morris SM, Acosta MT, Garg S, Green J, Huson S, Legius E et al (2016) Disease burden and symptom structure of autism in neurofibromatosis type 1: A study of the international NF1-ASD consortium team (INFACT). JAMA Psychiatry 73:1276","journal-title":"JAMA Psychiatry"},{"key":"2119_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1212\/WNL.0000000000005000","volume":"90","author":"SM Morris","year":"2018","unstructured":"Morris SM, Gutmann DH (2018) A genotype\u2013phenotype correlation for quantitative autistic trait burden in neurofibromatosis 1. Neurology 90:377","journal-title":"Neurology"},{"key":"2119_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13229-021-00481-3","volume":"13","author":"AK Chisholm","year":"2022","unstructured":"Chisholm AK, Haebich KM, Pride NA, Walsh KS, Lami F, Ure A et al (2022) Delineating the autistic phenotype in children with neurofibromatosis type 1. Mol Autism 13:3","journal-title":"Mol Autism"},{"key":"2119_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s11689-017-9198-5","volume":"9","author":"AB Rietman","year":"2017","unstructured":"Rietman AB, Oostenbrink R, Bongers S, Gaukema E, van Abeelen S, Hendriksen JG et al (2017) Motor problems in children with neurofibromatosis type 1. J Neurodev Disord 9:19","journal-title":"J Neurodev Disord"},{"key":"2119_CR22","first-page":"23m03514","volume":"25","author":"KS Brar","year":"2023","unstructured":"Brar KS, Trivedi C, Kaur N, Adnan M, Patel H, Beg U et al (2023) Prevalence of psychiatric comorbidities in patients with neurofibromatosis. Prim Care Companion CNS Disord 25:23m03514","journal-title":"Prim Care Companion CNS Disord"},{"key":"2119_CR23","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/dmcn.12769","volume":"57","author":"LA Barquero","year":"2015","unstructured":"Barquero LA, Sefcik AM, Cutting LE, Rimrodt SL (2015) Teaching reading to children with neurofibromatosis type 1: a clinical trial with random assignment to different approaches. Dev Med Child Neurol 57:1150\u20131158","journal-title":"Dev Med Child Neurol"},{"key":"2119_CR24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1017\/S135561772000106X","volume":"27","author":"SS Arnold","year":"2021","unstructured":"Arnold SS, Payne JM, McArthur G, North KN, Barton B (2021) Profiling the word reading abilities of School-Age children with neurofibromatosis type 1. J Int Neuropsychol Soc JINS 27:484\u2013496","journal-title":"J Int Neuropsychol Soc JINS"},{"key":"2119_CR25","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/dmcn.14144","volume":"61","author":"NS Eby","year":"2019","unstructured":"Eby NS, Griffith JL, Gutmann DH, Morris SM (2019) Adaptive functioning in children with neurofibromatosis type 1: relationship to cognition, behavior, and magnetic resonance imaging. Dev Med Child Neurol 61:972\u2013978","journal-title":"Dev Med Child Neurol"},{"key":"2119_CR26","first-page":"313","volume":"17","author":"JM Payne","year":"2011","unstructured":"Payne JM, Hyman SL, Shores EA, North KN (2011) Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Child Neuropsychol J Norm Abnorm Dev Child Adolesc 17:313\u2013329","journal-title":"Child Neuropsychol J Norm Abnorm Dev Child Adolesc"},{"key":"2119_CR27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/dmcn.14489","volume":"62","author":"Y Hou","year":"2020","unstructured":"Hou Y, Allen T, Wolters PL, Toledo-Tamula MA, Martin S, Baldwin A et al (2020) Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromas. Dev Med Child Neurol 62:977\u2013984","journal-title":"Dev Med Child Neurol"},{"key":"2119_CR28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s13023-021-02051-5","volume":"16","author":"A Roy","year":"2021","unstructured":"Roy A, Roulin J-L, Gras-Le Guen C, Corbat M-L, Barbarot S (2021) Executive functions and quality of life in children with neurofibromatosis type 1. Orphanet J Rare Dis 16:420","journal-title":"Orphanet J Rare Dis"},{"key":"2119_CR29","first-page":"318","volume":"28","author":"KM Haebich","year":"2022","unstructured":"Haebich KM, Dao DP, Pride NA, Barton B, Walsh KS, Maier A et al (2022) The mediating role of ADHD symptoms between executive function and social skills in children with neurofibromatosis type 1. Child Neuropsychol J Norm Abnorm Dev Child Adolesc 28:318\u2013336","journal-title":"Child Neuropsychol J Norm Abnorm Dev Child Adolesc"},{"key":"2119_CR30","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.3390\/cancers13246336","volume":"13","author":"U Sorrentino","year":"2021","unstructured":"Sorrentino U, Bellonzi S, Mozzato C, Brasson V, Toldo I, Parrozzani R et al (2021) Epilepsy in NF1: epidemiologic, genetic, and clinical features. A monocentric retrospective study in a cohort of 784 patients. Cancers 13:6336","journal-title":"Cancers"},{"key":"2119_CR31","first-page":"70","volume":"60","author":"K Hirabaru","year":"2018","unstructured":"Hirabaru K, Matsuo M (2018) Neurological comorbidity in children with neurofibromatosis type 1. Pediatr Int Off J Jpn Pediatr Soc 60:70\u201375","journal-title":"Pediatr Int Off J Jpn Pediatr Soc"},{"key":"2119_CR32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/ajmg.a.61069","volume":"179","author":"AM Kongkriangkai","year":"2019","unstructured":"Kongkriangkai AM, King C, Martin LJ, Wakefield E, Prada CE, Kelly-Mancuso G et al (2019) Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis type 1. Am J Med Genet A 179:602\u2013607","journal-title":"Am J Med Genet A"},{"key":"2119_CR33","doi-asserted-by":"crossref","unstructured":"Pacot L, Blok M, Vidaud D, Fertitta L, Laurendeau I, Coustier A et al (2025) Refined genotype-phenotype correlations in neurofibromatosis type 1 patients with NF1 point variants. J Med Genet jmg-2025-110783","DOI":"10.1136\/jmg-2025-110783"},{"key":"2119_CR34","doi-asserted-by":"publisher","first-page":"e136262","DOI":"10.1172\/jci.insight.136262","volume":"5","author":"MM Tabata","year":"2020","unstructured":"Tabata MM, Li S, Knight P, Bakker A, Sarin KY (2020) Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry. JCI Insight 5:e136262","journal-title":"JCI Insight"},{"key":"2119_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/gcc.2870040411","volume":"4","author":"W Xu","year":"1992","unstructured":"Xu W, Mulligan LM, Ponder MA, Liu L, Smith BA, Mathew CG et al (1992) Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis. Genes Chromosomes Cancer 4:337\u2013342","journal-title":"Genes Chromosomes Cancer"},{"key":"2119_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/ng0293-122","volume":"3","author":"E Legius","year":"1993","unstructured":"Legius E, Marchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3:122\u2013126","journal-title":"Nat Genet"},{"key":"2119_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/humu.1380040202","volume":"4","author":"M Upadhyaya","year":"1994","unstructured":"Upadhyaya M, Shaw DJ, Harper PS (1994) Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and polymorphisms in the NF1 gene. Hum Mutat 4:83\u2013101","journal-title":"Hum Mutat"},{"key":"2119_CR38","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJM199706123362404","volume":"336","author":"L Side","year":"1997","unstructured":"Side L, Taylor B, Cayouette M, Conner E, Thompson P, Luce M et al (1997) Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 336:1713\u20131720","journal-title":"N Engl J Med"},{"key":"2119_CR39","doi-asserted-by":"crossref","unstructured":"Gutmann DH, Donahoe J, Brown T, James CD, Perry A (2000) Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Appl Neurobiol. \/08\/10 ed. 2000;26:361\u20137","DOI":"10.1046\/j.1365-2990.2000.00258.x"},{"key":"2119_CR40","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1212\/WNL.61.10.1397","volume":"61","author":"DH Gutmann","year":"2003","unstructured":"Gutmann DH, James CD, Poyhonen M, Louis DN, Ferner R, Guha A et al (2003) Molecular analysis of Astrocytomas presenting after age 10 in individuals with NF1. Neurology 61:1397\u20131400","journal-title":"Neurology"},{"key":"2119_CR41","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/jnen\/60.9.917","volume":"60","author":"L Kluwe","year":"2001","unstructured":"Kluwe L, Hagel C, Tatagiba M, Thomas S, Stavrou D, Ostertag H et al (2001) Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic Astrocytomas. J Neuropathol Exp Neurol 60:917\u2013920","journal-title":"J Neuropathol Exp Neurol"},{"key":"2119_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/humu.21387","volume":"32","author":"C Garcia-Linares","year":"2011","unstructured":"Garcia-Linares C, Fern\u00e1ndez-Rodr\u00edguez J, Terribas E, Mercad\u00e9 J, Pros E, Benito L et al (2011) Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: importance of copy neutral LOH. Hum Mutat 32:78\u201390","journal-title":"Hum Mutat"},{"key":"2119_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41588-025-02097-2","volume":"57","author":"TRW Oliver","year":"2025","unstructured":"Oliver TRW, Lawson ARJ, Lee-Six H, Tollit A, Jung H, Hooks Y et al (2025) Cancer-independent somatic mutation of the wild-type NF1 allele in normal tissues in neurofibromatosis type 1. Nat Genet 57:515\u2013521","journal-title":"Nat Genet"},{"key":"2119_CR44","doi-asserted-by":"crossref","unstructured":"Chan A, Zhang K, Martin G, Bano S, Chatterjee J, Mahto S et al (2024) Maternal obesogenic diet operates at the tumor cell of origin to increase incidence and decrease latency of Neurofibromatosis Type 1 optic pathway glioma. Neuro-Oncol 5;26(12):2339\u20132351","DOI":"10.1093\/neuonc\/noae136"},{"key":"2119_CR45","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jpsychires.2021.06.002","volume":"140","author":"M-M Geoffray","year":"2021","unstructured":"Geoffray M-M, Robinson L, Ramamurthy K, Manderson L, O\u2019Flaherty J, Lehtonen A et al (2021) Predictors of cognitive, behavioural and academic difficulties in NF1. J Psychiatr Res 140:545\u2013550","journal-title":"J Psychiatr Res"},{"key":"2119_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40478-024-01735-w","volume":"12","author":"J Chatterjee","year":"2024","unstructured":"Chatterjee J, Koleske JP, Chao A, Sauerbeck AD, Chen J-K, Qi X et al (2024) Brain injury drives optic glioma formation through neuron-glia signaling. Acta Neuropathol Commun 12:21","journal-title":"Acta Neuropathol Commun"},{"key":"2119_CR47","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1158\/2159-8290.CD-18-0156","volume":"9","author":"KJ Radomska","year":"2019","unstructured":"Radomska KJ, Coulpier F, Gresset A, Schmitt A, Debbiche A, Lemoine S et al (2019) Cellular origin, tumor progression, and pathogenic mechanisms of cutaneous neurofibromas revealed by mice with Nf1 knockout in boundary cap cells. Cancer Discov 9:130\u2013147","journal-title":"Cancer Discov"},{"key":"2119_CR48","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1046\/j.1523-1747.1999.00609.x","volume":"112","author":"RP Atit","year":"1999","unstructured":"Atit RP, Crowe MJ, Greenhalgh DG, Wenstrup RJ, Ratner N (1999) The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol 112:835\u2013842","journal-title":"J Invest Dermatol"},{"key":"2119_CR49","first-page":"216","volume":"195","author":"MM Daston","year":"1992","unstructured":"Daston MM, Ratner N (1992) Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev Dyn Off Publ Am Assoc Anat 195:216\u2013226","journal-title":"Dev Dyn Off Publ Am Assoc Anat"},{"key":"2119_CR50","doi-asserted-by":"crossref","unstructured":"Gutmann DH, Parada LF, Silva AJ, Ratner N (2012) Neurofibromatosis type 1: modeling CNS dysfunction. J Neurosci. \/10\/12 ed. 2012;32:14087\u201393","DOI":"10.1523\/JNEUROSCI.3242-12.2012"},{"key":"2119_CR51","doi-asserted-by":"publisher","first-page":"dmm049362","DOI":"10.1242\/dmm.049362","volume":"15","author":"C Anastasaki","year":"2022","unstructured":"Anastasaki C, Orozco P, Gutmann DH (2022) RAS and beyond: the many faces of the neurofibromatosis type 1 protein. Dis Model Mech 15:dmm049362","journal-title":"Dis Model Mech"},{"key":"2119_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0959-437X(95)90053-5","volume":"5","author":"F McCormick","year":"1995","unstructured":"McCormick F (1995) Ras signaling and NF1. Curr Opin Genet Dev 5:51\u201355","journal-title":"Curr Opin Genet Dev"},{"key":"2119_CR53","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41388-021-02156-y","volume":"41","author":"J Mo","year":"2022","unstructured":"Mo J, Moye SL, McKay RM, Le LQ (2022) Neurofibromin and suppression of tumorigenesis: beyond the GAP. Oncogene 41:1235\u20131251","journal-title":"Oncogene"},{"key":"2119_CR54","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s42003-023-04815-0","volume":"6","author":"J B\u00e1ez-Flores","year":"2023","unstructured":"B\u00e1ez-Flores J, Rodr\u00edguez-Mart\u00edn M, Lacal J (2023) The therapeutic potential of neurofibromin signaling pathways and binding partners. Commun Biol 6:436","journal-title":"Commun Biol"},{"key":"2119_CR55","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrc3911","volume":"15","author":"N Ratner","year":"2015","unstructured":"Ratner N, Miller SJ (2015) A rasopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer 15:290\u2013301","journal-title":"Nat Rev Cancer"},{"key":"2119_CR56","doi-asserted-by":"crossref","unstructured":"Anastasaki C, Gutmann DH (2014) Neuronal NF1\/RAS regulation of cyclic AMP requires atypical PKC activation. Hum Mol Genet. 2014\/07\/30 ed. ;23:6712\u201321","DOI":"10.1093\/hmg\/ddu389"},{"key":"2119_CR57","doi-asserted-by":"publisher","first-page":"dmm049422","DOI":"10.1242\/dmm.049422","volume":"15","author":"AH Miller","year":"2022","unstructured":"Miller AH, Halloran MC (2022) Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment. Dis Model Mech 15:dmm049422","journal-title":"Dis Model Mech"},{"key":"2119_CR58","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ng0397-281","volume":"15","author":"AJ Silva","year":"1997","unstructured":"Silva AJ, Frankland PW, Marowitz Z, Friedman E, Laszlo GS, Cioffi D et al (1997) A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet 15:281\u2013284","journal-title":"Nat Genet"},{"key":"2119_CR59","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature711","volume":"415","author":"RM Costa","year":"2002","unstructured":"Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M et al (2002) Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415:526\u2013530","journal-title":"Nature"},{"key":"2119_CR60","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","volume":"15","author":"W Li","year":"2005","unstructured":"Li W, Cui Y, Kushner SA, Brown RAM, Jentsch JD, Frankland PW et al (2005) The HMG-CoA reductase inhibitor Lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol CB 15:1961\u20131967","journal-title":"Curr Biol CB"},{"key":"2119_CR61","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/mp.2015.48","volume":"20","author":"A Omrani","year":"2015","unstructured":"Omrani A, van der Vaart T, Mientjes E, van Woerden GM, Hojjati MR, Li KW et al (2015) HCN channels are a novel therapeutic target for cognitive dysfunction in neurofibromatosis type 1. Mol Psychiatry 20:1311\u20131321","journal-title":"Mol Psychiatry"},{"key":"2119_CR62","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/aur.1853","volume":"11","author":"SE Maloney","year":"2018","unstructured":"Maloney SE, Chandler KC, Anastasaki C, Rieger MA, Gutmann DH, Dougherty JD (2018) Characterization of early communicative behavior in mouse models of neurofibromatosis type 1. Autism Res Off J Int Soc Autism Res 11:44\u201358","journal-title":"Autism Res Off J Int Soc Autism Res"},{"key":"2119_CR63","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/nn.3822","volume":"17","author":"AI Molosh","year":"2014","unstructured":"Molosh AI, Johnson PL, Spence JP, Arendt D, Federici LM, Bernabe C et al (2014) Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase. Nat Neurosci 17:1583\u20131590","journal-title":"Nat Neurosci"},{"key":"2119_CR64","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/gbb.12305","volume":"15","author":"LI Petrella","year":"2016","unstructured":"Petrella LI, Cai Y, Sereno JV, Gon\u00e7alves SI, Silva AJ, Castelo-Branco M (2016) Brain and behaviour phenotyping of a mouse model of neurofibromatosis type-1: an MRI\/DTI study on social cognition. Genes Brain Behav 15:637\u2013646","journal-title":"Genes Brain Behav"},{"key":"2119_CR65","doi-asserted-by":"crossref","unstructured":"Robinson A, Kloog Y, Stein R, Assaf Y (2010) Motor deficits and neurofibromatosis type 1 (NF1)-associated MRI impairments in a mouse model of NF1. NMR Biomed. \/06\/30 ed. 2010;23:1173\u201380","DOI":"10.1002\/nbm.1546"},{"key":"2119_CR66","doi-asserted-by":"crossref","unstructured":"van der Vaart T, van Woerden GM, Elgersma Y, de Zeeuw CI, Schonewille M (2011) Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum. Genes Brain Behav. \/03\/01 ed. 2011;10:404\u20139","DOI":"10.1111\/j.1601-183X.2011.00685.x"},{"key":"2119_CR67","doi-asserted-by":"publisher","first-page":"e48983","DOI":"10.7554\/eLife.48983","volume":"8","author":"JE Robinson","year":"2019","unstructured":"Robinson JE, Coughlin GM, Hori AM, Cho JR, Mackey ED, Turan Z et al (2019) Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1. eLife 8:e48983","journal-title":"eLife"},{"key":"2119_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s11689-019-9304-y","volume":"12","author":"JL Lukkes","year":"2020","unstructured":"Lukkes JL, Drozd HP, Fitz SD, Molosh AI, Clapp DW, Shekhar A (2020) Guanfacine treatment improves ADHD phenotypes of impulsivity and hyperactivity in a neurofibromatosis type 1 mouse model. J Neurodev Disord 12:2","journal-title":"J Neurodev Disord"},{"key":"2119_CR69","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1093\/hmg\/ddx264","volume":"26","author":"HT Nguyen","year":"2017","unstructured":"Nguyen HT, Hinman MN, Guo X, Sharma A, Arakawa H, Luo G et al (2017) Neurofibromatosis type 1 alternative splicing is a key regulator of ras\/erk signaling and learning behaviors in mice. Hum Mol Genet 26:3797\u20133807","journal-title":"Hum Mol Genet"},{"key":"2119_CR70","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","volume":"135","author":"Y Cui","year":"2008","unstructured":"Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH et al (2008) Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 135:549\u2013560","journal-title":"Cell"},{"key":"2119_CR71","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.cub.2016.09.010","volume":"26","author":"K Xie","year":"2016","unstructured":"Xie K, Colgan LA, Dao MT, Muntean BS, Sutton LP, Orlandi C et al (2016) NF1 is a direct G protein effector essential for opioid signaling to Ras in the striatum. Curr Biol CB 26:2992\u20133003","journal-title":"Curr Biol CB"},{"key":"2119_CR72","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1093\/hmg\/ddq382","volume":"19","author":"JA Brown","year":"2010","unstructured":"Brown JA, Emnett RJ, White CR, Yuede CM, Conyers SB, O\u2019Malley KL et al (2010) Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. Hum Mol Genet 19:4515\u20134528","journal-title":"Hum Mol Genet"},{"key":"2119_CR73","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ana.23793","volume":"73","author":"KA Diggs-Andrews","year":"2013","unstructured":"Diggs-Andrews KA, Tokuda K, Izumi Y, Zorumski CF, Wozniak DF, Gutmann DH (2013) Dopamine deficiency underlies learning deficits in Neurofibromatosis-1 mice. Ann Neurol 73:309\u2013315","journal-title":"Ann Neurol"},{"key":"2119_CR74","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ana.24093","volume":"75","author":"KA Diggs-Andrews","year":"2014","unstructured":"Diggs-Andrews KA, Brown JA, Gianino SM, Rubin JB, Wozniak DF, Gutmann DH (2014) Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1. Ann Neurol 75:309\u2013316","journal-title":"Ann Neurol"},{"key":"2119_CR75","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1523\/JNEUROSCI.3096-13.2014","volume":"34","author":"AF Oliveira","year":"2014","unstructured":"Oliveira AF, Yasuda R (2014) Neurofibromin is the major Ras inactivator in dendritic spines. J Neurosci Off J Soc Neurosci 34:776\u2013783","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2119_CR76","doi-asserted-by":"publisher","first-page":"e05151","DOI":"10.7554\/eLife.05151","volume":"3","author":"E Kim","year":"2014","unstructured":"Kim E, Wang Y, Kim S-J, Bornhorst M, Jecrois ES, Anthony TE et al (2014) Transient Inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. eLife 3:e05151","journal-title":"eLife"},{"key":"2119_CR77","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.cell.2012.06.034","volume":"150","author":"Y Wang","year":"2012","unstructured":"Wang Y, Kim E, Wang X, Novitch BG, Yoshikawa K, Chang L-S et al (2012) ERK Inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities. Cell 150:816\u2013830","journal-title":"Cell"},{"key":"2119_CR78","doi-asserted-by":"publisher","first-page":"13141","DOI":"10.1073\/pnas.1004829107","volume":"107","author":"C Shilyansky","year":"2010","unstructured":"Shilyansky C, Karlsgodt KH, Cummings DM, Sidiropoulou K, Hardt M, James AS et al (2010) Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc Natl Acad Sci U S A 107:13141\u201313146","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2119_CR79","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.cortex.2014.10.019","volume":"64","author":"MJ Ribeiro","year":"2015","unstructured":"Ribeiro MJ, Violante IR, Bernardino I, Edden RAE, Castelo-Branco M (2015) Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1. Cortex J Devoted Study Nerv Syst Behav 64:194\u2013208","journal-title":"Cortex J Devoted Study Nerv Syst Behav"},{"key":"2119_CR80","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.1523\/JNEUROSCI.2235-19.2020","volume":"40","author":"M van Lier","year":"2020","unstructured":"van Lier M, Saiepour MH, Kole K, Cheyne JE, Zabouri N, Blok T et al (2020) Disruption of critical period plasticity in a mouse model of neurofibromatosis type 1. J Neurosci Off J Soc Neurosci 40:5495\u20135509","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2119_CR81","doi-asserted-by":"publisher","first-page":"105881","DOI":"10.1016\/j.nbd.2022.105881","volume":"174","author":"A Lacroix","year":"2022","unstructured":"Lacroix A, Proteau-Lemieux M, C\u00f4t\u00e9 S, Near J, Hui SCN, Edden RAE et al (2022) Multimodal assessment of the GABA system in patients with fragile-X syndrome and neurofibromatosis of type 1. Neurobiol Dis 174:105881","journal-title":"Neurobiol Dis"},{"key":"2119_CR82","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.expneurol.2011.09.005","volume":"232","author":"JA Brown","year":"2011","unstructured":"Brown JA, Xu J, Diggs-Andrews KA, Wozniak DF, Mach RH, Gutmann DH (2011) PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. Exp Neurol 232:333\u2013338","journal-title":"Exp Neurol"},{"key":"2119_CR83","doi-asserted-by":"crossref","unstructured":"Anastasaki C, Woo AS, Messiaen LM, Gutmann DH (2015) Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning. Hum Mol Genet. \/03\/20 ed. 2015;24:3518\u201328","DOI":"10.1093\/hmg\/ddv103"},{"key":"2119_CR84","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.expneurol.2016.06.005","volume":"283","author":"AI Boullerne","year":"2016","unstructured":"Boullerne AI (2016) The history of Myelin. Exp Neurol 283:431\u2013445","journal-title":"Exp Neurol"},{"key":"2119_CR85","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.conb.2013.09.008","volume":"23","author":"AS Saab","year":"2013","unstructured":"Saab AS, Tzvetanova ID, Nave K-A (2013) The role of Myelin and oligodendrocytes in axonal energy metabolism. Curr Opin Neurobiol 23:1065\u20131072","journal-title":"Curr Opin Neurobiol"},{"key":"2119_CR86","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/glia.23699","volume":"68","author":"S Song","year":"2020","unstructured":"Song S, Luo L, Sun B, Sun D (2020) Roles of glial ion transporters in brain diseases. Glia 68:472\u2013494","journal-title":"Glia"},{"key":"2119_CR87","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.1523\/JNEUROSCI.23-18-07207.2003","volume":"23","author":"MR Bennett","year":"2003","unstructured":"Bennett MR, Rizvi TA, Karyala S, McKinnon RD, Ratner N (2003) Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants. J Neurosci Off J Soc Neurosci 23:7207\u20137217","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2119_CR88","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/s41593-024-01654-y","volume":"27","author":"Y Pan","year":"2024","unstructured":"Pan Y, Hysinger JD, Yal\u00e7\u0131n B, Lennon JJ, Byun YG, Raghavan P et al (2024) Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in mice. Nat Neurosci 27:1555\u20131564","journal-title":"Nat Neurosci"},{"key":"2119_CR89","doi-asserted-by":"crossref","unstructured":"Gonzalez PP, Kim J, Galvao RP, Cruickshanks N, Abounader R, Zong H (2018) p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression. Glia. \/02\/03 ed. 2018;66:999\u20131015","DOI":"10.1002\/glia.23297"},{"key":"2119_CR90","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1093\/hmg\/ddq395","volume":"19","author":"J-S Lee","year":"2010","unstructured":"Lee J-S, Padmanabhan A, Shin J, Zhu S, Guo F, Kanki JP et al (2010) Oligodendrocyte progenitor cell numbers and migration are regulated by the zebrafish orthologs of the NF1 tumor suppressor gene. Hum Mol Genet 19:4643\u20134653","journal-title":"Hum Mol Genet"},{"key":"2119_CR91","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1177\/08830738211008736","volume":"36","author":"LT Tam","year":"2021","unstructured":"Tam LT, Ng NN, McKenna ES, Bruckert L, Yeom KW, Campen CJ (2021) Effects of age on white matter microstructure in children with neurofibromatosis type 1. J Child Neurol 36:894\u2013900","journal-title":"J Child Neurol"},{"key":"2119_CR92","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.celrep.2013.08.011","volume":"4","author":"DA Mayes","year":"2013","unstructured":"Mayes DA, Rizvi TA, Titus-Mitchell H, Oberst R, Ciraolo GM, Vorhees CV et al (2013) Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in Myelin and vasculature. Cell Rep 4:1197\u20131212","journal-title":"Cell Rep"},{"key":"2119_CR93","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.celrep.2017.03.073","volume":"19","author":"A L\u00f3pez-Ju\u00e1rez","year":"2017","unstructured":"L\u00f3pez-Ju\u00e1rez A, Titus HE, Silbak SH, Pressler JW, Rizvi TA, Bogard M et al (2017) Oligodendrocyte Nf1 controls aberrant Notch activation and regulates Myelin structure and behavior. Cell Rep 19:545\u2013557","journal-title":"Cell Rep"},{"key":"2119_CR94","doi-asserted-by":"publisher","first-page":"22506","DOI":"10.1073\/pnas.2008391117","volume":"117","author":"J Asleh","year":"2020","unstructured":"Asleh J, Shofty B, Cohen N, Kavushansky A, L\u00f3pez-Ju\u00e1rez A, Constantini S et al (2020) Brain-wide structural and functional disruption in mice with oligodendrocyte-specific Nf1 deletion is rescued by Inhibition of nitric oxide synthase. Proc Natl Acad Sci U S A 117:22506\u201322513","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2119_CR95","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/cancers16030477","volume":"16","author":"DP Hernandez","year":"2024","unstructured":"Hernandez DP, Cruz DM, Martinez CS, Garcia LM, Figueroa A, Villarreal M et al (2024) Gender-Specific fine motor skill learning is impaired by Myelin-Targeted neurofibromatosis type 1 gene mutation. Cancers 16:477","journal-title":"Cancers"},{"key":"2119_CR96","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1002\/glia.24432","volume":"71","author":"P de Blank","year":"2023","unstructured":"de Blank P, Nishiyama A, L\u00f3pez-Ju\u00e1rez A (2023) A new era for Myelin research in neurofibromatosis type 1. Glia 71:2701\u20132719","journal-title":"Glia"},{"key":"2119_CR97","doi-asserted-by":"crossref","unstructured":"Fattah M, Raman MM, Reiss AL, Green T (1991) PTPN11 Mutations in the Ras-MAPK Signaling Pathway Affect Human White Matter Microstructure. Cereb Cortex N Y N. 2021;31:1489\u201399","DOI":"10.1093\/cercor\/bhaa299"},{"key":"2119_CR98","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.3390\/ijms26083515","volume":"26","author":"G Reynolds","year":"2025","unstructured":"Reynolds G, Gazzin A, Carli D, Massuras S, Cardaropoli S, Luca M et al (2025) Update on the clinical and molecular characterization of Noonan syndrome and other rasopathies: A retrospective study and systematic review. Int J Mol Sci 26:3515","journal-title":"Int J Mol Sci"},{"key":"2119_CR99","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3174\/ajnr.A5611","volume":"39","author":"MN Cizmeci","year":"2018","unstructured":"Cizmeci MN, Lequin M, Lichtenbelt KD, Chitayat D, Kannu P, James AG et al (2018) Characteristic MR imaging findings of the neonatal brain in rasopathies. AJNR Am J Neuroradiol 39:1146\u20131152","journal-title":"AJNR Am J Neuroradiol"},{"key":"2119_CR100","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12887-023-04166-z","volume":"23","author":"VE Failoc-Rojas","year":"2023","unstructured":"Failoc-Rojas VE, Ugaz PAQ, Le\u00f3n DAL, Ze\u00f1a-\u00d1a\u00f1ez S (2023) Fatal leukodystrophy in Costello syndrome: a case report. BMC Pediatr 23:374","journal-title":"BMC Pediatr"},{"key":"2119_CR101","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1017\/S1462399408000902","volume":"10","author":"WE Tidyman","year":"2008","unstructured":"Tidyman WE, Rauen KA, Noonan (2008) Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway. Expert Rev Mol Med 10:e37","journal-title":"Expert Rev Mol Med"},{"key":"2119_CR102","doi-asserted-by":"publisher","first-page":"fcae274","DOI":"10.1093\/braincomms\/fcae274","volume":"6","author":"M Siqueiros-Sanchez","year":"2024","unstructured":"Siqueiros-Sanchez M, Dai E, McGhee CA, McNab JA, Raman MM, Green T (2024) Impact of pathogenic variants of the Ras-mitogen-activated protein kinase pathway on major white matter tracts in the human brain. Brain Commun 14;6(4):fcae274","journal-title":"Brain Commun"},{"key":"2119_CR103","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/glia.23209","volume":"65","author":"HE Titus","year":"2017","unstructured":"Titus HE, L\u00f3pez-Ju\u00e1rez A, Silbak SH, Rizvi TA, Bogard M, Ratner N (2017) Oligodendrocyte RasG12V expressed in its endogenous locus disrupts Myelin structure through increased MAPK, nitric oxide, and Notch signaling. Glia 65:1990\u20132002","journal-title":"Glia"},{"key":"2119_CR104","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1523\/JNEUROSCI.3515-13.2014","volume":"34","author":"LA Ehrman","year":"2014","unstructured":"Ehrman LA, Nardini D, Ehrman S, Rizvi TA, Gulick J, Krenz M et al (2014) The protein tyrosine phosphatase Shp2 is required for the generation of oligodendrocyte progenitor cells and myelination in the mouse telencephalon. J Neurosci Off J Soc Neurosci 34:3767\u20133778","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2119_CR105","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/glia.21016","volume":"58","author":"Y Zhu","year":"2010","unstructured":"Zhu Y, Park J, Hu X, Zheng K, Li H, Cao Q et al (2010) Control of oligodendrocyte generation and proliferation by Shp2 protein tyrosine phosphatase. Glia 58:1407\u20131414","journal-title":"Glia"},{"key":"2119_CR106","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1471-4159.2010.06596.x","volume":"113","author":"E Kuo","year":"2010","unstructured":"Kuo E, Park DK, Tzvetanova ID, Leiton CV, Cho BS, Colognato H (2010) Tyrosine phosphatases Shp1 and Shp2 have unique and opposing roles in oligodendrocyte development. J Neurochem 113:200\u2013212","journal-title":"J Neurochem"},{"key":"2119_CR107","doi-asserted-by":"publisher","first-page":"e1008108","DOI":"10.1371\/journal.pgen.1008108","volume":"15","author":"MC Holter","year":"2019","unstructured":"Holter MC, Hewitt LT, Koebele SV, Judd JM, Xing L, Bimonte-Nelson HA et al (2019) The Noonan Syndrome-linked Raf1L613V mutation drives increased glial number in the mouse cortex and enhanced learning. PLoS Genet 15:e1008108","journal-title":"PLoS Genet"},{"key":"2119_CR108","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1523\/JNEUROSCI.4403-12.2013","volume":"33","author":"A Ishii","year":"2013","unstructured":"Ishii A, Furusho M, Bansal R (2013) Sustained activation of ERK1\/2 MAPK in oligodendrocytes and Schwann cells enhances Myelin growth and stimulates oligodendrocyte progenitor expansion. J Neurosci Off J Soc Neurosci 33:175\u2013186","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2119_CR109","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.1523\/JNEUROSCI.0137-12.2012","volume":"32","author":"A Ishii","year":"2012","unstructured":"Ishii A, Fyffe-Maricich SL, Furusho M, Miller RH, Bansal R (2012) ERK1\/ERK2 MAPK signaling is required to increase Myelin thickness independent of oligodendrocyte differentiation and initiation of Myelination. J Neurosci Off J Soc Neurosci 32:8855\u20138864","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2119_CR110","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/glia.23606","volume":"67","author":"N Suo","year":"2019","unstructured":"Suo N, Guo Y-E, He B, Gu H, Xie X (2019) Inhibition of MAPK\/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases. Glia 67:1320\u20131332","journal-title":"Glia"},{"key":"2119_CR111","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1212\/WNL.0000000000012436","volume":"97","author":"C Bettegowda","year":"2021","unstructured":"Bettegowda C, Upadhayaya M, Evans DG, Kim A, Mathios D, Hanemann CO et al (2021) Genotype-Phenotype correlations in neurofibromatosis and their potential clinical use. Neurology 97:S91\u2013S98","journal-title":"Neurology"},{"key":"2119_CR112","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/genes13071130","volume":"13","author":"F Napolitano","year":"2022","unstructured":"Napolitano F, Dell\u2019Aquila M, Terracciano C, Franzese G, Gentile MT, Piluso G et al (2022) Genotype-Phenotype correlations in neurofibromatosis type 1: identification of novel and recurrent NF1 gene variants and correlations with neurocognitive phenotype. Genes 13:1130","journal-title":"Genes"},{"key":"2119_CR113","first-page":"424","volume":"54","author":"LM Kayes","year":"1994","unstructured":"Kayes LM, Burke W, Riccardi VM, Bennett R, Ehrlich P, Rubenstein A et al (1994) Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet 54:424\u2013436","journal-title":"Am J Hum Genet"},{"key":"2119_CR114","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/(SICI)1096-8628(19970303)69:1<98::AID-AJMG19>3.0.CO;2-J","volume":"69","author":"BL Wu","year":"1997","unstructured":"Wu BL, Schneider GH, Korf BR (1997) Deletion of the entire NF1 gene causing distinct manifestations in a family. Am J Med Genet 69:98\u2013101","journal-title":"Am J Med Genet"},{"key":"2119_CR115","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s004390050746","volume":"102","author":"M Upadhyaya","year":"1998","unstructured":"Upadhyaya M, Ruggieri M, Maynard J, Osborn M, Hartog C, Mudd S et al (1998) Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet 102:591\u2013597","journal-title":"Hum Genet"},{"key":"2119_CR116","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1542\/peds.103.6.1257","volume":"103","author":"D Carmi","year":"1999","unstructured":"Carmi D, Shohat M, Metzker A, Dickerman Z (1999) Growth, puberty, and endocrine functions in patients with sporadic or Familial neurofibromatosis type 1: a longitudinal study. Pediatrics 103:1257\u20131262","journal-title":"Pediatrics"},{"key":"2119_CR117","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1086\/374821","volume":"72","author":"T De Raedt","year":"2003","unstructured":"De Raedt T, Brems H, Wolkenstein P, Vidaud D, Pilotti S, Perrone F et al (2003) Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 72:1288\u20131292","journal-title":"Am J Hum Genet"},{"key":"2119_CR118","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ajmg.a.30346","volume":"131","author":"MJ Descheemaeker","year":"2004","unstructured":"Descheemaeker MJ, Roelandts K, De Raedt T, Brems H, Fryns JP, Legius E (2004) Intelligence in individuals with a neurofibromatosis type 1 microdeletion. Am J Med Genet A 131:325\u2013326","journal-title":"Am J Med Genet A"},{"key":"2119_CR119","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/jmg.2003.014761","volume":"41","author":"M Venturin","year":"2004","unstructured":"Venturin M, Guarnieri P, Natacci F, Stabile M, Tenconi R, Clementi M et al (2004) Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet 41:35\u201341","journal-title":"J Med Genet"},{"key":"2119_CR120","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1136\/jmg.2005.034256","volume":"43","author":"KA Mensink","year":"2006","unstructured":"Mensink KA, Ketterling RP, Flynn HC, Knudson RA, Lindor NM, Heese BA et al (2006) Connective tissue dysplasia in five new patients with NF1 microdeletions: further expansion of phenotype and review of the literature. J Med Genet 43:e8","journal-title":"J Med Genet"},{"key":"2119_CR121","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/jmg.2009.075937","volume":"47","author":"V-F Mautner","year":"2010","unstructured":"Mautner V-F, Kluwe L, Friedrich RE, Roehl AC, Bammert S, H\u00f6gel J et al (2010) Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4\u00a0mb type-1 NF1 deletions. J Med Genet 47:623\u2013630","journal-title":"J Med Genet"},{"key":"2119_CR122","doi-asserted-by":"publisher","first-page":"E1506","DOI":"10.1002\/humu.21271","volume":"31","author":"E Pasmant","year":"2010","unstructured":"Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel M-J et al (2010) NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat 31:E1506\u20131518","journal-title":"Hum Mutat"},{"key":"2119_CR123","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/cge.12072","volume":"84","author":"R Nguyen","year":"2013","unstructured":"Nguyen R, Mir TS, Kluwe L, Jett K, Kentsch M, Mueller G et al (2013) Cardiac characterization of 16 patients with large NF1 gene deletions. Clin Genet 84:344\u2013349","journal-title":"Clin Genet"},{"key":"2119_CR124","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00439-021-02363-3","volume":"140","author":"H Kehrer-Sawatzki","year":"2021","unstructured":"Kehrer-Sawatzki H, Cooper DN (2021) Classification of NF1 microdeletions and its importance for Establishing genotype\/phenotype correlations in patients with NF1 microdeletions. Hum Genet 140:1635\u20131649","journal-title":"Hum Genet"},{"key":"2119_CR125","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/cancers13122963","volume":"13","author":"L Pacot","year":"2021","unstructured":"Pacot L, Vidaud D, Sabbagh A, Laurendeau I, Briand-Suleau A, Coustier A et al (2021) Severe phenotype in patients with large deletions of NF1. Cancers 13:2963","journal-title":"Cancers"},{"key":"2119_CR126","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/ddg.14707","volume":"20","author":"H Kehrer-Sawatzki","year":"2022","unstructured":"Kehrer-Sawatzki H, B\u00e4zner U, Kr\u00e4mer J, Lewerenz J, Pfeiffer C (2022) The NF1 microdeletion syndrome: early genetic diagnosis facilitates the management of a clinically defined disease. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG 20:273\u2013277","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG"},{"key":"2119_CR127","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/ajmg.a.36313","volume":"164A","author":"S Ekvall","year":"2014","unstructured":"Ekvall S, Sj\u00f6rs K, Jonzon A, Vihinen M, Anner\u00e9n G, Bondeson M-L (2014) Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome. Am J Med Genet A 164A:579\u2013587","journal-title":"Am J Med Genet A"},{"key":"2119_CR128","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/ejhg.2014.243","volume":"23","author":"V Pinna","year":"2015","unstructured":"Pinna V, Lanari V, Daniele P, Consoli F, Agolini E, Margiotti K et al (2015) p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas. Eur J Hum Genet EJHG 23:1068\u20131071","journal-title":"Eur J Hum Genet EJHG"},{"key":"2119_CR129","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/humu.22832","volume":"36","author":"K Rojnueangnit","year":"2015","unstructured":"Rojnueangnit K, Xie J, Gomes A, Sharp A, Callens T, Chen Y et al (2015) High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: Genotype-Phenotype correlation. Hum Mutat 36:1052\u20131063","journal-title":"Hum Mutat"},{"key":"2119_CR130","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/ejhg.2015.93","volume":"23","author":"C Santoro","year":"2015","unstructured":"Santoro C, Maietta A, Giugliano T, Melis D, Perrotta S, Nigro V et al (2015) Arg(1809) substitution in neurofibromin: further evidence of a genotype-phenotype correlation in neurofibromatosis type 1. Eur J Hum Genet EJHG 23:1460\u20131461","journal-title":"Eur J Hum Genet EJHG"},{"key":"2119_CR131","doi-asserted-by":"crossref","unstructured":"Anastasaki C, Wegscheid ML, Hartigan K, Papke JB, Kopp ND, Chen J et al (2020) Human iPSC-Derived Neurons and Cerebral Organoids Establish Differential Effects of Germline NF1 Gene Mutations. Stem Cell Rep. \/04\/04 ed. 2020;14:541\u201350","DOI":"10.1016\/j.stemcr.2020.03.007"},{"key":"2119_CR132","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.molcel.2022.03.011","volume":"82","author":"M Chaker-Margot","year":"2022","unstructured":"Chaker-Margot M, Werten S, Dunzendorfer-Matt T, Lechner S, Ruepp A, Scheffzek K et al (2022) Structural basis of activation of the tumor suppressor protein neurofibromin. Mol Cell 82:1288\u20131296e5","journal-title":"Mol Cell"},{"key":"2119_CR133","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/humu.24290","volume":"43","author":"A Long","year":"2022","unstructured":"Long A, Liu H, Liu J, Daniel M, Bedwell DM, Korf B et al (2022) Analysis of patient-specific NF1 variants leads to functional insights for Ras signaling that can impact personalized medicine. Hum Mutat 43:30\u201341","journal-title":"Hum Mutat"},{"key":"2119_CR134","doi-asserted-by":"crossref","unstructured":"Sherekar M, Han SW, Ghirlando R, Messing S, Drew M, Rabara D et al (2020) Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. J Biol Chem. 2019\/12\/15 ed. ;295:1105\u201319","DOI":"10.1016\/S0021-9258(17)49919-4"},{"key":"2119_CR135","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-021-04024-x","volume":"599","author":"A Naschberger","year":"2021","unstructured":"Naschberger A, Baradaran R, Rupp B, Carroni M (2021) The structure of neurofibromin isoform 2 reveals different functional States. Nature 599:315\u2013319","journal-title":"Nature"},{"key":"2119_CR136","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41594-021-00687-2","volume":"28","author":"CJ Lupton","year":"2021","unstructured":"Lupton CJ, Bayly-Jones C, D\u2019Andrea L, Huang C, Schittenhelm RB, Venugopal H et al (2021) The cryo-EM structure of the human neurofibromin dimer reveals the molecular basis for neurofibromatosis type 1. Nat Struct Mol Biol 28:982\u2013988","journal-title":"Nat Struct Mol Biol"},{"key":"2119_CR137","doi-asserted-by":"publisher","first-page":"e2208960120","DOI":"10.1073\/pnas.2208960120","volume":"120","author":"LC Young","year":"2023","unstructured":"Young LC, Goldstein de Salazar R, Han S-W, Huang ZYS, Merk A, Drew M et al (2023) Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization. Proc Natl Acad Sci U S A 120:e2208960120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2119_CR138","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1038\/s41467-022-30466-6","volume":"13","author":"C Anastasaki","year":"2022","unstructured":"Anastasaki C, Mo J, Chen J-K, Chatterjee J, Pan Y, Scheaffer SM et al (2022) Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. Nat Commun 13:2785","journal-title":"Nat Commun"},{"key":"2119_CR139","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/neuonc\/noae054","volume":"26","author":"C Anastasaki","year":"2024","unstructured":"Anastasaki C, Chatterjee J, Koleske JP, Gao Y, Bozeman SL, Kernan CM et al (2024) NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma. Neuro-Oncol 26:1496\u20131508","journal-title":"Neuro-Oncol"},{"key":"2119_CR140","first-page":"759","volume":"9","author":"K Li","year":"2016","unstructured":"Li K, Turner AN, Chen M, Brosius SN, Schoeb TR, Messiaen LM et al (2016) Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I. Dis Model Mech 9:759\u2013767","journal-title":"Dis Model Mech"},{"key":"2119_CR141","doi-asserted-by":"crossref","unstructured":"Toonen JA, Anastasaki C, Smithson LJ, Gianino SM, Li K, Kesterson RA et al (2016) NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1. Hum Mol Genet. \/02\/26 ed. 2016;25:1703\u201313","DOI":"10.1093\/hmg\/ddw039"},{"key":"2119_CR142","doi-asserted-by":"crossref","unstructured":"Guo X, Pan Y, Gutmann DH (2019) Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia. Neuro Oncol. \/05\/22 ed. 2019;21:1250\u201362","DOI":"10.1093\/neuonc\/noz080"},{"key":"2119_CR143","doi-asserted-by":"crossref","unstructured":"Brossier NM, Thondapu S, Cobb OM, Dahiya S, Gutmann DH (2020) Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma. Neuro Oncol. \/10\/21 ed. 2021;23:625\u201337","DOI":"10.1093\/neuonc\/noaa237"},{"key":"2119_CR144","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/s41586-024-07525-7","volume":"630","author":"B Yal\u00e7\u0131n","year":"2024","unstructured":"Yal\u00e7\u0131n B, Pomrenze MB, Malacon K, Drexler R, Rogers AE, Shamardani K et al (2024) Myelin plasticity in the ventral tegmental area is required for opioid reward. Nature 630:677\u2013685","journal-title":"Nature"},{"key":"2119_CR145","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41583-023-00744-3","volume":"24","author":"KR Taylor","year":"2023","unstructured":"Taylor KR, Monje M (2023) Neuron-oligodendroglial interactions in health and malignant disease. Nat Rev Neurosci 24:733\u2013746","journal-title":"Nat Rev Neurosci"},{"key":"2119_CR146","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nn.3992","volume":"18","author":"JH Hines","year":"2015","unstructured":"Hines JH, Ravanelli AM, Schwindt R, Scott EK, Appel B (2015) Neuronal activity biases axon selection for myelination in vivo. Nat Neurosci 18:683\u2013689","journal-title":"Nat Neurosci"},{"key":"2119_CR147","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nn.3991","volume":"18","author":"S Mensch","year":"2015","unstructured":"Mensch S, Baraban M, Almeida R, Czopka T, Ausborn J, El Manira A et al (2015) Synaptic vesicle release regulates Myelin sheath number of individual oligodendrocytes in vivo. Nat Neurosci 18:628\u2013630","journal-title":"Nat Neurosci"},{"key":"2119_CR148","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41467-017-02719-2","volume":"9","author":"S Mitew","year":"2018","unstructured":"Mitew S, Gobius I, Fenlon LR, McDougall SJ, Hawkes D, Xing YL et al (2018) Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner. Nat Commun 9:306","journal-title":"Nat Commun"},{"key":"2119_CR149","doi-asserted-by":"publisher","first-page":"1252304","DOI":"10.1126\/science.1252304","volume":"344","author":"EM Gibson","year":"2014","unstructured":"Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, Wood LS et al (2014) Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science 344:1252304","journal-title":"Science"},{"key":"2119_CR150","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuroscience.2013.11.029","volume":"276","author":"S Mitew","year":"2014","unstructured":"Mitew S, Hay CM, Peckham H, Xiao J, Koenning M, Emery B (2014) Mechanisms regulating the development of oligodendrocytes and central nervous system Myelin. Neuroscience 276:29\u201347","journal-title":"Neuroscience"},{"key":"2119_CR151","doi-asserted-by":"publisher","first-page":"8122","DOI":"10.1038\/s41467-023-43920-w","volume":"14","author":"F Fiore","year":"2023","unstructured":"Fiore F, Alhalaseh K, Dereddi RR, Bodaleo Torres F, \u00c7oban I, Harb A et al (2023) Norepinephrine regulates calcium signals and fate of oligodendrocyte precursor cells in the mouse cerebral cortex. Nat Commun 14:8122","journal-title":"Nat Commun"},{"key":"2119_CR152","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1016\/j.cell.2025.05.031","volume":"188","author":"R Drexler","year":"2025","unstructured":"Drexler R, Drinnenberg A, Gavish A, Yal\u00e7in B, Shamardani K, Rogers AE et al (2025) Cholinergic neuronal activity promotes diffuse midline glioma growth through muscarinic signaling. Cell 188:4640\u20134657e30","journal-title":"Cell"},{"key":"2119_CR153","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/361258a0","volume":"361","author":"BA Barres","year":"1993","unstructured":"Barres BA, Raff MC (1993) Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature 361:258\u2013260","journal-title":"Nature"},{"key":"2119_CR154","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1126\/science.1254960","volume":"346","author":"IA McKenzie","year":"2014","unstructured":"McKenzie IA, Ohayon D, Li H, de Faria JP, Emery B, Tohyama K et al (2014) Motor skill learning requires active central myelination. Science 346:318\u2013322","journal-title":"Science"},{"key":"2119_CR155","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/nn.4351","volume":"19","author":"L Xiao","year":"2016","unstructured":"Xiao L, Ohayon D, McKenzie IA, Sinclair-Wilson A, Wright JL, Fudge AD et al (2016) Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning. Nat Neurosci 19:1210\u20131217","journal-title":"Nat Neurosci"},{"key":"2119_CR156","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41593-018-0121-5","volume":"21","author":"EG Hughes","year":"2018","unstructured":"Hughes EG, Orthmann-Murphy JL, Langseth AJ, Bergles DE (2018) Myelin remodeling through experience-dependent oligodendrogenesis in the adult somatosensory cortex. Nat Neurosci 21:696\u2013706","journal-title":"Nat Neurosci"},{"key":"2119_CR157","doi-asserted-by":"crossref","unstructured":"Pan S, Mayoral SR, Choi HS, Chan JR, Kheirbek MA (2020) Preservation of a remote fear memory requires new myelin formation. Nat Neurosci. \/02\/12 ed. 2020;23:487\u201399","DOI":"10.1038\/s41593-019-0582-1"},{"key":"2119_CR158","doi-asserted-by":"crossref","unstructured":"Steadman PE, Xia F, Ahmed M, Mocle AJ, Penning ARA, Geraghty AC et al (2019) Disruption of Oligodendrogenesis Impairs Memory Consolidation in Adult Mice. Neuron. \/11\/23 ed. 2020;105:150\u2013164 e6","DOI":"10.1016\/j.neuron.2019.10.013"},{"key":"2119_CR159","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41586-024-07853-8","volume":"633","author":"W Xin","year":"2024","unstructured":"Xin W, Kaneko M, Roth RH, Zhang A, Nocera S, Ding JB et al (2024) Oligodendrocytes and Myelin limit neuronal plasticity in visual cortex. Nature 633:856\u2013863","journal-title":"Nature"},{"key":"2119_CR160","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neuron.2019.04.032","volume":"103","author":"AC Geraghty","year":"2019","unstructured":"Geraghty AC, Gibson EM, Ghanem RA, Greene JJ, Ocampo A, Goldstein AK et al (2019) Loss of adaptive myelination contributes to methotrexate Chemotherapy-Related cognitive impairment. Neuron 103:250\u2013265e8","journal-title":"Neuron"},{"key":"2119_CR161","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.neuron.2019.10.013","volume":"105","author":"PE Steadman","year":"2020","unstructured":"Steadman PE, Xia F, Ahmed M, Mocle AJ, Penning ARA, Geraghty AC et al (2020) Disruption of oligodendrogenesis impairs memory consolidation in adult mice. Neuron 105:150\u2013164e6","journal-title":"Neuron"},{"key":"2119_CR162","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41593-022-01052-2","volume":"25","author":"JK Knowles","year":"2022","unstructured":"Knowles JK, Xu H, Soane C, Batra A, Saucedo T, Frost E et al (2022) Maladaptive myelination promotes generalized epilepsy progression. Nat Neurosci 25:596\u2013606","journal-title":"Nat Neurosci"},{"key":"2119_CR163","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cell.2018.10.049","volume":"176","author":"EM Gibson","year":"2019","unstructured":"Gibson EM, Nagaraja S, Ocampo A, Tam LT, Wood LS, Pallegar PN et al (2019) Methotrexate chemotherapy induces persistent Tri-glial dysregulation that underlies chemotherapy-Related cognitive impairment. Cell 176:43\u201355e13","journal-title":"Cell"},{"key":"2119_CR164","doi-asserted-by":"crossref","unstructured":"Potter BS, Mendoza L, Potter BS, Mendoza L (2019) Cognitive issues experienced by individuals living with neurofibromatosis. Neurofibromatosis - Curr Trends Future Dir. IntechOpen","DOI":"10.5772\/intechopen.90020"},{"key":"2119_CR165","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/35012083","volume":"405","author":"DE Bergles","year":"2000","unstructured":"Bergles DE, Roberts JDB, Somogyi P, Jahr CE (2000) Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 405:187\u2013191","journal-title":"Nature"},{"key":"2119_CR166","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nn1162","volume":"7","author":"S Lin","year":"2004","unstructured":"Lin S, Bergles DE (2004) Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus. Nat Neurosci 7:24\u201332","journal-title":"Nat Neurosci"},{"key":"2119_CR167","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nature04302","volume":"438","author":"R K\u00e1rad\u00f3ttir","year":"2005","unstructured":"K\u00e1rad\u00f3ttir R, Cavelier P, Bergersen LH, Attwell D (2005) NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438:1162\u20131166","journal-title":"Nature"},{"key":"2119_CR168","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/S1740925X09990081","volume":"5","author":"M Kukley","year":"2009","unstructured":"Kukley M, Dietrich D (2009) Kainate receptors and signal integration by NG2 glial cells. Neuron Glia Biol 5:13\u201320","journal-title":"Neuron Glia Biol"},{"key":"2119_CR169","doi-asserted-by":"publisher","first-page":"e1001993","DOI":"10.1371\/journal.pbio.1001993","volume":"12","author":"D Sakry","year":"2014","unstructured":"Sakry D, Neitz A, Singh J, Frischknecht R, Marongiu D, Binam\u00e9 F et al (2014) Oligodendrocyte precursor cells modulate the neuronal network by activity-dependent ectodomain cleavage of glial NG2. PLoS Biol 12:e1001993","journal-title":"PLoS Biol"},{"key":"2119_CR170","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.neuron.2015.10.046","volume":"88","author":"F Birey","year":"2015","unstructured":"Birey F, Kloc M, Chavali M, Hussein I, Wilson M, Christoffel DJ et al (2015) Genetic and Stress-Induced loss of NG2 glia triggers emergence of Depressive-like behaviors through reduced secretion of FGF2. Neuron 88:941\u2013956","journal-title":"Neuron"},{"key":"2119_CR171","doi-asserted-by":"publisher","first-page":"e0127222","DOI":"10.1371\/journal.pone.0127222","volume":"10","author":"D Sakry","year":"2015","unstructured":"Sakry D, Yigit H, Dimou L, Trotter J (2015) Oligodendrocyte precursor cells synthesize neuromodulatory factors. PLoS ONE 10:e0127222","journal-title":"PLoS ONE"},{"key":"2119_CR172","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41467-022-29020-1","volume":"13","author":"L-P Fang","year":"2022","unstructured":"Fang L-P, Zhao N, Caudal LC, Chang H-F, Zhao R, Lin C-H et al (2022) Impaired bidirectional communication between interneurons and oligodendrocyte precursor cells affects social cognitive behavior. Nat Commun 13:1394","journal-title":"Nat Commun"},{"key":"2119_CR173","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-017-1747-1","volume":"134","author":"N Hagemeyer","year":"2017","unstructured":"Hagemeyer N, Hanft K-M, Akriditou M-A, Unger N, Park ES, Stanley ER et al (2017) Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood. Acta Neuropathol (Berl) 134:441\u2013458","journal-title":"Acta Neuropathol (Berl)"},{"key":"2119_CR174","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41593-020-0654-2","volume":"23","author":"AN Hughes","year":"2020","unstructured":"Hughes AN, Appel B (2020) Microglia phagocytose Myelin sheaths to modify developmental Myelination. Nat Neurosci 23:1055\u20131066","journal-title":"Nat Neurosci"},{"key":"2119_CR175","doi-asserted-by":"crossref","unstructured":"Daginakatte GC, Gianino SM, Zhao NW, Parsadanian AS, Gutmann DH (2008) Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation. Cancer Res. \/12\/17 ed. 2008;68:10358\u201366","DOI":"10.1158\/0008-5472.CAN-08-2506"},{"key":"2119_CR176","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/hmg\/ddm059","volume":"16","author":"GC Daginakatte","year":"2007","unstructured":"Daginakatte GC, Gutmann DH (2007) Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. Hum Mol Genet 16:1098\u20131112","journal-title":"Hum Mol Genet"},{"key":"2119_CR177","doi-asserted-by":"publisher","first-page":"105030","DOI":"10.1016\/j.nbd.2020.105030","volume":"144","author":"N Elmadany","year":"2020","unstructured":"Elmadany N, Logiacco F, Buonfiglioli A, Haage VC, Wright-Jin EC, Schattenberg A et al (2020) Neurofibromatosis 1 - Mutant microglia exhibit sexually-dimorphic Cyclic AMP-dependent purinergic defects. Neurobiol Dis 144:105030","journal-title":"Neurobiol Dis"},{"key":"2119_CR178","doi-asserted-by":"crossref","unstructured":"Simmons GW, Pong WW, Emnett RJ, White CR, Gianino SM, Rodriguez FJ et al (2010) Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth. J Neuropathol Exp Neurol. \/12\/16 ed. 2011;70:51\u201362","DOI":"10.1097\/NEN.0b013e3182032d37"},{"key":"2119_CR179","doi-asserted-by":"crossref","unstructured":"Toonen JA, Solga AC, Ma Y, Gutmann DH (2016) Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology. J Exp Med. \/12\/08 ed. 2017;214:17\u201325","DOI":"10.1084\/jem.20160447"},{"key":"2119_CR180","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gad.310797.117","volume":"32","author":"Y Pan","year":"2018","unstructured":"Pan Y, Xiong M, Chen R, Ma Y, Corman C, Maricos M et al (2018) Athymic mice reveal a requirement for T-cell-microglia interactions in Establishing a microenvironment supportive of Nf1 low-grade glioma growth. Genes Dev 32:491\u20134962018\/04\/11 ed","journal-title":"Genes Dev"},{"key":"2119_CR181","doi-asserted-by":"crossref","unstructured":"Solga AC, Pong WW, Kim KY, Cimino PJ, Toonen JA, Walker J et al (2015) RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth. Neoplasia. \/11\/21 ed. 2015;17:776\u201388","DOI":"10.1016\/j.neo.2015.10.002"},{"key":"2119_CR182","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/neuonc\/noab130","volume":"24","author":"A De Andrade Costa","year":"2022","unstructured":"De Andrade Costa A, Chatterjee J, Cobb O, Sanapala S, Scheaffer S, Guo X et al (2022) RNA sequence analysis reveals ITGAL\/CD11A as a stromal regulator of murine low-grade glioma growth. Neuro-Oncol 24:14\u201326","journal-title":"Neuro-Oncol"},{"key":"2119_CR183","doi-asserted-by":"crossref","unstructured":"Pong WW, Higer SB, Gianino SM, Emnett RJ, Gutmann DH (2013) Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation. Ann Neurol. \/02\/21 ed. 2013;73:303\u20138","DOI":"10.1002\/ana.23813"},{"key":"2119_CR184","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40478-023-01525-w","volume":"11","author":"F Logiacco","year":"2023","unstructured":"Logiacco F, Grzegorzek LC, Cordell EC, Popp O, Mertins P, Gutmann DH et al (2023) Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. Acta Neuropathol Commun 11:36","journal-title":"Acta Neuropathol Commun"},{"key":"2119_CR185","doi-asserted-by":"publisher","first-page":"dmm049861","DOI":"10.1242\/dmm.049861","volume":"16","author":"LD Kuhrt","year":"2023","unstructured":"Kuhrt LD, Motta E, Elmadany N, Weidling H, Fritsche-Guenther R, Efe IE et al (2023) Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia. Dis Model Mech 16:dmm049861","journal-title":"Dis Model Mech"},{"key":"2119_CR186","doi-asserted-by":"publisher","first-page":"e1002605","DOI":"10.1371\/journal.pbio.1002605","volume":"15","author":"N Camargo","year":"2017","unstructured":"Camargo N, Goudriaan A, van Deijk A-LF, Otte WM, Brouwers JF, Lodder H et al (2017) Oligodendroglial myelination requires astrocyte-derived lipids. PLoS Biol 15:e1002605","journal-title":"PLoS Biol"},{"key":"2119_CR187","doi-asserted-by":"publisher","first-page":"13949","DOI":"10.1523\/JNEUROSCI.3395-07.2007","volume":"27","author":"JL Orthmann-Murphy","year":"2007","unstructured":"Orthmann-Murphy JL, Freidin M, Fischer E, Scherer SS, Abrams CK (2007) Two distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins. J Neurosci Off J Soc Neurosci 27:13949\u201313957","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2119_CR188","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.nbd.2011.03.003","volume":"42","author":"SK Wasseff","year":"2011","unstructured":"Wasseff SK, Scherer SS (2011) Cx32 and Cx47 mediate oligodendrocyte:astrocyte and oligodendrocyte:oligodendrocyte gap junction coupling. Neurobiol Dis 42:506\u2013513","journal-title":"Neurobiol Dis"},{"key":"2119_CR189","doi-asserted-by":"publisher","first-page":"7499","DOI":"10.1523\/JNEUROSCI.0392-12.2012","volume":"32","author":"O Tress","year":"2012","unstructured":"Tress O, Maglione M, May D, Pivneva T, Richter N, Seyfarth J et al (2012) Panglial gap junctional communication is essential for maintenance of Myelin in the CNS. J Neurosci Off J Soc Neurosci 32:7499\u20137518","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2119_CR190","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.1073\/pnas.1811013115","volume":"115","author":"DJ Dutta","year":"2018","unstructured":"Dutta DJ, Woo DH, Lee PR, Pajevic S, Bukalo O, Huffman WC et al (2018) Regulation of Myelin structure and conduction velocity by perinodal astrocytes. Proc Natl Acad Sci U S A 115:11832\u201311837","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2119_CR191","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1038\/sj.onc.1202829","volume":"18","author":"DH Gutmann","year":"1999","unstructured":"Gutmann DH, Loehr A, Zhang Y, Kim J, Henkemeyer M, Cashen A (1999) Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene 18:4450\u20134459","journal-title":"Oncogene"},{"key":"2119_CR192","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0006-8993(98)01133-0","volume":"816","author":"TA Rizvi","year":"1999","unstructured":"Rizvi TA, Akunuru S, de Courten-Myers G, Switzer RC, Nordlund ML, Ratner N (1999) Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor. Brain Res 816:111\u2013123","journal-title":"Brain Res"},{"key":"2119_CR193","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1093\/hmg\/10.26.3009","volume":"10","author":"DH Gutmann","year":"2001","unstructured":"Gutmann DH, Wu YL, Hedrick NM, Zhu Y, Guha A, Parada LF (2001) Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. Hum Mol Genet 10:3009\u20133016","journal-title":"Hum Mol Genet"},{"key":"2119_CR194","doi-asserted-by":"publisher","first-page":"5100","DOI":"10.1128\/MCB.22.14.5100-5113.2002","volume":"22","author":"ML Bajenaru","year":"2002","unstructured":"Bajenaru ML, Zhu Y, Hedrick NM, Donahoe J, Parada LF, Gutmann DH (2002) Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for Astrocytoma formation. Mol Cell Biol 22:5100\u20135113","journal-title":"Mol Cell Biol"},{"key":"2119_CR195","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1158\/0008-5472.236.65.1","volume":"65","author":"B Dasgupta","year":"2005","unstructured":"Dasgupta B, Li W, Perry A, Gutmann DH (2005) Glioma formation in neurofibromatosis 1 reflects Preferential activation of K-RAS in astrocytes. Cancer Res 65:236\u2013245","journal-title":"Cancer Res"},{"key":"2119_CR196","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/glia.20845","volume":"57","author":"T-H Yeh","year":"2009","unstructured":"Yeh T-H, Lee DY, Gianino SM, Gutmann DH (2009) Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. Glia 57:1239\u20131249","journal-title":"Glia"},{"key":"2119_CR197","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/00005072-199507000-00013","volume":"54","author":"ML Nordlund","year":"1995","unstructured":"Nordlund ML, Rizvi TA, Brannan CI, Ratner N (1995) Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains. J Neuropathol Exp Neurol 54:588\u2013600","journal-title":"J Neuropathol Exp Neurol"},{"key":"2119_CR198","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1101\/gad.862101","volume":"15","author":"Y Zhu","year":"2001","unstructured":"Zhu Y, Romero MI, Ghosh P, Ye Z, Charnay P, Rushing EJ et al (2001) Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev 15:859\u2013876","journal-title":"Genes Dev"},{"key":"2119_CR199","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1097\/00001756-199911260-00019","volume":"10","author":"JW Mandell","year":"1999","unstructured":"Mandell JW, VandenBerg SR (1999) ERK\/MAP kinase is chronically activated in human reactive astrocytes. NeuroReport 10:3567\u20133572","journal-title":"NeuroReport"},{"key":"2119_CR200","doi-asserted-by":"publisher","first-page":"e176631","DOI":"10.1172\/JCI176631","volume":"135","author":"M Kang","year":"2025","unstructured":"Kang M, Choi J, Han J, Araki T, Kim S-W, Ryu H-H et al (2025) Aberrant ERK signaling in astrocytes impairs learning and memory in RASopathy-associated BRAF mutant mouse models. J Clin Invest 135:e176631","journal-title":"J Clin Invest"},{"key":"2119_CR201","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1126\/science.aad3839","volume":"351","author":"H-H Tsai","year":"2016","unstructured":"Tsai H-H, Niu J, Munji R, Davalos D, Chang J, Zhang H et al (2016) Oligodendrocyte precursors migrate along vasculature in the developing nervous system. Science 351:379\u2013384","journal-title":"Science"},{"key":"2119_CR202","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.neuron.2020.09.033","volume":"108","author":"M Chavali","year":"2020","unstructured":"Chavali M, Ulloa-Navas MJ, P\u00e9rez-Borred\u00e1 P, Garcia-Verdugo JM, McQuillen PS, Huang EJ et al (2020) Wnt-Dependent Oligodendroglial-Endothelial interactions regulate white matter vascularization and attenuate injury. Neuron 108:1130\u20131145e5","journal-title":"Neuron"},{"key":"2119_CR203","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41593-019-0369-4","volume":"22","author":"J Niu","year":"2019","unstructured":"Niu J, Tsai H-H, Hoi KK, Huang N, Yu G, Kim K et al (2019) Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation. Nat Neurosci 22:709\u2013718","journal-title":"Nat Neurosci"},{"key":"2119_CR204","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ng1059","volume":"33","author":"AD Gitler","year":"2003","unstructured":"Gitler AD, Zhu Y, Ismat FA, Lu MM, Yamauchi Y, Parada LF et al (2003) Nf1 has an essential role in endothelial cells. Nat Genet 33:75\u201379","journal-title":"Nat Genet"},{"key":"2119_CR205","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1167\/iovs.17-22588","volume":"59","author":"H Zhang","year":"2018","unstructured":"Zhang H, Hudson FZ, Xu Z, Tritz R, Rojas M, Patel C et al (2018) Neurofibromin deficiency induces endothelial cell proliferation and retinal neovascularization. Invest Ophthalmol Vis Sci 59:2520","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2119_CR206","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1289\/ehp.7688","volume":"113","author":"BP Lanphear","year":"2005","unstructured":"Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC et al (2005) Low-level environmental lead exposure and children\u2019s intellectual function: an international pooled analysis. Environ Health Perspect 113:894\u2013899","journal-title":"Environ Health Perspect"},{"key":"2119_CR207","doi-asserted-by":"publisher","first-page":"e1054","DOI":"10.1542\/peds.2009-0738","volume":"124","author":"TE Froehlich","year":"2009","unstructured":"Froehlich TE, Lanphear BP, Auinger P, Hornung R, Epstein JN, Braun J et al (2009) Association of tobacco and lead exposures with attention-deficit\/hyperactivity disorder. Pediatrics 124:e1054\u20131063","journal-title":"Pediatrics"},{"key":"2119_CR208","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-publhealth-031912-114413","volume":"36","author":"BP Lanphear","year":"2015","unstructured":"Lanphear BP (2015) The impact of toxins on the developing brain. Annu Rev Public Health 36:211\u2013230","journal-title":"Annu Rev Public Health"},{"key":"2119_CR209","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1001\/jama.2017.1712","volume":"317","author":"A Reuben","year":"2017","unstructured":"Reuben A, Caspi A, Belsky DW, Broadbent J, Harrington H, Sugden K et al (2017) Association of childhood blood lead levels with cognitive function and socioeconomic status at age 38 years and with IQ change and socioeconomic mobility between childhood and adulthood. JAMA 317:1244\u20131251","journal-title":"JAMA"},{"key":"2119_CR210","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S0022-3476(97)70099-4","volume":"131","author":"SN Mattson","year":"1997","unstructured":"Mattson SN, Riley EP, Gramling L, Delis DC, Jones KL (1997) Heavy prenatal alcohol exposure with or without physical features of fetal alcohol syndrome leads to IQ deficits. J Pediatr 131:718\u2013721","journal-title":"J Pediatr"},{"key":"2119_CR211","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1289\/ehp.1104494","volume":"120","author":"MR Karagas","year":"2012","unstructured":"Karagas MR, Choi AL, Oken E, Horvat M, Schoeny R, Kamai E et al (2012) Evidence on the human health effects of low-level Methylmercury exposure. Environ Health Perspect 120:799\u2013806","journal-title":"Environ Health Perspect"},{"key":"2119_CR212","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1289\/ehp.1003160","volume":"119","author":"V Rauh","year":"2011","unstructured":"Rauh V, Arunajadai S, Horton M, Perera F, Hoepner L, Barr DB et al (2011) Seven-year neurodevelopmental scores and prenatal exposure to chlorpyrifos, a common agricultural pesticide. Environ Health Perspect 119:1196\u20131201","journal-title":"Environ Health Perspect"},{"key":"2119_CR213","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neuro.2013.09.003","volume":"39","author":"MT Mu\u00f1oz-Quezada","year":"2013","unstructured":"Mu\u00f1oz-Quezada MT, Lucero BA, Barr DB, Steenland K, Levy K, Ryan PB et al (2013) Neurodevelopmental effects in children associated with exposure to organophosphate pesticides: a systematic review. Neurotoxicology 39:158\u2013168","journal-title":"Neurotoxicology"},{"key":"2119_CR214","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1093\/aje\/kwab173","volume":"190","author":"SK Sagiv","year":"2021","unstructured":"Sagiv SK, Kogut K, Harley K, Bradman A, Morga N, Eskenazi B (2021) Gestational exposure to organophosphate pesticides and longitudinally assessed behaviors related to Attention-Deficit\/Hyperactivity disorder and executive function. Am J Epidemiol 190:2420\u20132431","journal-title":"Am J Epidemiol"},{"key":"2119_CR215","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM199609123351104","volume":"335","author":"JL Jacobson","year":"1996","unstructured":"Jacobson JL, Jacobson SW (1996) Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med 335:783\u2013789","journal-title":"N Engl J Med"},{"key":"2119_CR216","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1289\/ehp.11058","volume":"116","author":"PW Stewart","year":"2008","unstructured":"Stewart PW, Lonky E, Reihman J, Pagano J, Gump BB, Darvill T (2008) The relationship between prenatal PCB exposure and intelligence (IQ) in 9-year-old children. Environ Health Perspect 116:1416\u20131422","journal-title":"Environ Health Perspect"},{"issue":"Suppl 6","key":"2119_CR217","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1289\/ehp.95103s673","volume":"103","author":"PM Rodier","year":"1995","unstructured":"Rodier PM (1995) Developing brain as a target of toxicity. Environ Health Perspect 103(Suppl 6):73\u201376","journal-title":"Environ Health Perspect"},{"issue":"Suppl 3","key":"2119_CR218","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1289\/ehp.00108s3511","volume":"108","author":"D Rice","year":"2000","unstructured":"Rice D, Barone S (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108(Suppl 3):511\u2013533","journal-title":"Environ Health Perspect"},{"key":"2119_CR219","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/toxsci\/kfae100","volume":"202","author":"LL Liu","year":"2024","unstructured":"Liu LL, Emir U, Gu H, Sang LT, Sawiak SJ, Cannon JR et al (2024) Demyelination and impaired oligodendrogenesis in the corpus callosum following lead exposure. Toxicol Sci Off J Soc Toxicol 202:123\u2013141","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"key":"2119_CR220","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0300-483X(86)90018-1","volume":"42","author":"E Tiffany-Castiglioni","year":"1986","unstructured":"Tiffany-Castiglioni E, Zmudzki J, Bratton GR (1986) Cellular targets of lead neurotoxicity: in vitro models. Toxicology 42:303\u2013315","journal-title":"Toxicology"},{"key":"2119_CR221","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/taap.2001.9219","volume":"174","author":"W Deng","year":"2001","unstructured":"Deng W, McKinnon RD, Poretz RD (2001) Lead exposure delays the differentiation of oligodendroglial progenitors in vitro. Toxicol Appl Pharmacol 174:235\u2013244","journal-title":"Toxicol Appl Pharmacol"},{"key":"2119_CR222","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.neuro.2009.07.007","volume":"30","author":"CJ Brubaker","year":"2009","unstructured":"Brubaker CJ, Schmithorst VJ, Haynes EN, Dietrich KN, Egelhoff JC, Lindquist DM et al (2009) Altered myelination and axonal integrity in adults with childhood lead exposure: a diffusion tensor imaging study. Neurotoxicology 30:867\u2013875","journal-title":"Neurotoxicology"},{"key":"2119_CR223","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1289\/ehp.1002176","volume":"119","author":"KM Cecil","year":"2011","unstructured":"Cecil KM, Dietrich KN, Altaye M, Egelhoff JC, Lindquist DM, Brubaker CJ et al (2011) Proton magnetic resonance spectroscopy in adults with childhood lead exposure. Environ Health Perspect 119:403\u2013408","journal-title":"Environ Health Perspect"},{"key":"2119_CR224","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/glia.23164","volume":"65","author":"J Newville","year":"2017","unstructured":"Newville J, Valenzuela CF, Li L, Jantzie LL, Cunningham LA (2017) Acute oligodendrocyte loss with persistent white matter injury in a third trimester equivalent mouse model of fetal alcohol spectrum disorder. Glia 65:1317\u20131332","journal-title":"Glia"},{"key":"2119_CR225","doi-asserted-by":"publisher","first-page":"105181","DOI":"10.1016\/j.nbd.2020.105181","volume":"148","author":"N Darbinian","year":"2021","unstructured":"Darbinian N, Darbinyan A, Merabova N, Bajwa A, Tatevosian G, Martirosyan D et al (2021) Ethanol-mediated alterations in oligodendrocyte differentiation in the developing brain. Neurobiol Dis 148:105181","journal-title":"Neurobiol Dis"},{"key":"2119_CR226","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40478-022-01378-9","volume":"10","author":"F Marguet","year":"2022","unstructured":"Marguet F, Brosolo M, Friocourt G, Sauvestre F, Marcorelles P, Lesueur C et al (2022) Oligodendrocyte lineage is severely affected in human alcohol-exposed foetuses. Acta Neuropathol Commun 10:74","journal-title":"Acta Neuropathol Commun"},{"key":"2119_CR227","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1111\/j.1530-0277.2008.00750.x","volume":"32","author":"C Lebel","year":"2008","unstructured":"Lebel C, Rasmussen C, Wyper K, Walker L, Andrew G, Yager J et al (2008) Brain diffusion abnormalities in children with fetal alcohol spectrum disorder. Alcohol Clin Exp Res 32:1732\u20131740","journal-title":"Alcohol Clin Exp Res"},{"key":"2119_CR228","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/j.1530-0277.2009.01021.x","volume":"33","author":"JR Wozniak","year":"2009","unstructured":"Wozniak JR, Muetzel RL, Mueller BA, McGee CL, Freerks MA, Ward EE et al (2009) Microstructural corpus callosum anomalies in children with prenatal alcohol exposure: an extension of previous diffusion tensor imaging findings. Alcohol Clin Exp Res 33:1825\u20131835","journal-title":"Alcohol Clin Exp Res"},{"key":"2119_CR229","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41593-024-01599-2","volume":"27","author":"EF Cohn","year":"2024","unstructured":"Cohn EF, Clayton BLL, Madhavan M, Lee KA, Yacoub S, Fedorov Y et al (2024) Pervasive environmental chemicals impair oligodendrocyte development. Nat Neurosci 27:836\u2013845","journal-title":"Nat Neurosci"},{"key":"2119_CR230","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2008.12.026","volume":"259","author":"MD Saulsbury","year":"2009","unstructured":"Saulsbury MD, Heyliger SO, Wang K, Johnson DJ (2009) Chlorpyrifos induces oxidative stress in oligodendrocyte progenitor cells. Toxicology 259:1\u20139","journal-title":"Toxicology"},{"key":"2119_CR231","doi-asserted-by":"publisher","first-page":"110047","DOI":"10.1016\/j.envres.2020.110047","volume":"191","author":"MA van den Dries","year":"2020","unstructured":"van den Dries MA, Lamballais S, El Marroun H, Pronk A, Spaan S, Ferguson KK et al (2020) Prenatal exposure to organophosphate pesticides and brain morphology and white matter microstructure in preadolescents. Environ Res 191:110047","journal-title":"Environ Res"},{"key":"2119_CR232","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev.publhealth.23.112001.112349","volume":"23","author":"GW Evans","year":"2002","unstructured":"Evans GW, Kantrowitz E (2002) Socioeconomic status and health: the potential role of environmental risk exposure. Annu Rev Public Health 23:303\u2013331","journal-title":"Annu Rev Public Health"},{"key":"2119_CR233","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.envint.2013.06.017","volume":"59","author":"J Tyrrell","year":"2013","unstructured":"Tyrrell J, Melzer D, Henley W, Galloway TS, Osborne NJ (2013) Associations between socioeconomic status and environmental toxicant concentrations in adults in the USA: NHANES 2001\u20132010. Environ Int 59:328\u2013335","journal-title":"Environ Int"},{"key":"2119_CR234","doi-asserted-by":"publisher","first-page":"103303","DOI":"10.1016\/j.healthplace.2024.103303","volume":"89","author":"A Peluso","year":"2024","unstructured":"Peluso A, Rastogi D, Klasky HB, Logan J, Maguire D, Grant J et al (2024) Environmental determinants of health: measuring multiple physical environmental exposures at the united States census tract level. Health Place 89:103303","journal-title":"Health Place"},{"key":"2119_CR235","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41431-022-01149-z","volume":"30","author":"K Doser","year":"2022","unstructured":"Doser K, Belmonte F, Andersen KK, \u00d8stergaard JR, Hove H, Handrup MM et al (2022) School performance of children with neurofibromatosis 1: a nationwide population-based study. Eur J Hum Genet EJHG 30:1405\u20131412","journal-title":"Eur J Hum Genet EJHG"},{"key":"2119_CR236","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.toxlet.2022.12.013","volume":"375","author":"Z-C Li","year":"2023","unstructured":"Li Z-C, Zhao Y-S, Lin J-J, Wang L-L, Song H-X, Gan C-L et al (2023) Sodium para-aminosalicylic acid ameliorates brain neuroinflammation and behavioral deficits in juvenile lead-exposed rats by modulating MAPK signaling pathway and alpha-synuclein. Toxicol Lett 375:48\u201358","journal-title":"Toxicol Lett"},{"key":"2119_CR237","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.toxlet.2017.03.001","volume":"271","author":"M Fujimura","year":"2017","unstructured":"Fujimura M, Usuki F (2017) Site-specific neural hyperactivity via the activation of MAPK and PKA\/CREB pathways triggers neuronal degeneration in methylmercury-intoxicated mice. Toxicol Lett 271:66\u201373","journal-title":"Toxicol Lett"},{"key":"2119_CR238","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.taap.2012.06.005","volume":"263","author":"JE Lee","year":"2012","unstructured":"Lee JE, Park JH, Shin IC, Koh HC (2012) Reactive oxygen species regulated mitochondria-mediated apoptosis in PC12 cells exposed to Chlorpyrifos. Toxicol Appl Pharmacol 263:148\u2013162","journal-title":"Toxicol Appl Pharmacol"},{"key":"2119_CR239","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1471-0528.2006.01180.x","volume":"114","author":"N Heslehurst","year":"2007","unstructured":"Heslehurst N, Ells LJ, Simpson H, Batterham A, Wilkinson J, Summerbell CD (2007) Trends in maternal obesity incidence rates, demographic predictors, and health inequalities in 36,821 women over a 15-year period. BJOG Int J Obstet Gynaecol 114:187\u2013194","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"2119_CR240","unstructured":"Hales CM, Carroll MD, Fryar CD, Ogden CL (2020) Prevalence of obesity and severe obesity among adults: united states, 2017\u20132018. NCHS Data Brief (360):1\u20138"},{"key":"2119_CR241","doi-asserted-by":"publisher","first-page":"04200","DOI":"10.7189\/jogh.14.04200","volume":"14","author":"P Wang","year":"2024","unstructured":"Wang P, Huang S, Wang R, Shi X, Xu H, Peng J et al (2024) Global burden and cross-country inequalities in diseases associated with high body mass index from 1990 to 2019: result from the global burden of disease study 2019. J Glob Health 14:04200","journal-title":"J Glob Health"},{"issue":"32","key":"2119_CR242","first-page":"550","volume":"2008","author":"A Rodriguez","year":"2005","unstructured":"Rodriguez A, Miettunen J, Henriksen TB, Olsen J, Obel C, Taanila A et al (2005) Maternal adiposity prior to pregnancy is associated with ADHD symptoms in offspring: evidence from three prospective pregnancy cohorts. Int J Obes 2008(32):550\u2013557","journal-title":"Int J Obes"},{"key":"2119_CR243","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1111\/1471-0528.13909","volume":"123","author":"SJ Pugh","year":"2016","unstructured":"Pugh SJ, Hutcheon JA, Richardson GA, Brooks MM, Himes KP, Day NL et al (2016) Gestational weight gain, prepregnancy body mass index and offspring attention-deficit hyperactivity disorder symptoms and behaviour at age 10. BJOG Int J Obstet Gynaecol 123:2094\u20132103","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"2119_CR244","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00787-017-1027-6","volume":"27","author":"CH Andersen","year":"2018","unstructured":"Andersen CH, Thomsen PH, Nohr EA, Lemcke S (2018) Maternal body mass index before pregnancy as a risk factor for ADHD and autism in children. Eur Child Adolesc Psychiatry 27:139\u2013148","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2119_CR245","first-page":"1344","volume":"37","author":"SN Hinkle","year":"2013","unstructured":"Hinkle SN, Sharma AJ, Kim SY, Schieve LA (2013) Maternal prepregnancy weight status and associations with children\u2019s development and disabilities at kindergarten. Int J Obes 2005 37:1344\u20131351","journal-title":"Int J Obes 2005"},{"key":"2119_CR246","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.earlhumdev.2015.03.002","volume":"91","author":"K Pola\u0144ska","year":"2015","unstructured":"Pola\u0144ska K, Muszy\u0144ski P, Sobala W, Dziewirska E, Merecz-Kot D, Hanke W (2015) Maternal lifestyle during pregnancy and child psychomotor development - Polish mother and child cohort study. Early Hum Dev 91:317\u2013325","journal-title":"Early Hum Dev"},{"key":"2119_CR247","first-page":"900","volume":"104","author":"JW van der Burg","year":"2015","unstructured":"van der Burg JW, Allred EN, Kuban K, O\u2019Shea TM, Dammann O, Leviton A (2015) Maternal obesity and development of the preterm newborn at 2 years. Acta Paediatr Oslo nor 1992 104:900\u2013903","journal-title":"Acta Paediatr Oslo nor 1992"},{"key":"2119_CR248","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/oby.21040","volume":"23","author":"A Wylie","year":"2015","unstructured":"Wylie A, Sundaram R, Kus C, Ghassabian A, Yeung EH (2015) Maternal prepregnancy obesity and achievement of infant motor developmental milestones in the upstate KIDS study. Obes Silver Spring Md 23:907\u2013913","journal-title":"Obes Silver Spring Md"},{"key":"2119_CR249","doi-asserted-by":"publisher","first-page":"e37758","DOI":"10.1371\/journal.pone.0037758","volume":"7","author":"C Buss","year":"2012","unstructured":"Buss C, Entringer S, Davis EP, Hobel CJ, Swanson JM, Wadhwa PD et al (2012) Impaired executive function mediates the association between maternal pre-pregnancy body mass index and child ADHD symptoms. PLoS ONE 7:e37758","journal-title":"PLoS ONE"},{"key":"2119_CR250","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/pr.2017.43","volume":"82","author":"TH Mina","year":"2017","unstructured":"Mina TH, Lahti M, Drake AJ, Denison FC, R\u00e4ikk\u00f6nen K, Norman JE et al (2017) Prenatal exposure to maternal very severe obesity is associated with impaired neurodevelopment and executive functioning in children. Pediatr Res 82:47\u201354","journal-title":"Pediatr Res"},{"key":"2119_CR251","doi-asserted-by":"publisher","first-page":"e2121429","DOI":"10.1001\/jamanetworkopen.2021.21429","volume":"4","author":"E Oken","year":"2021","unstructured":"Oken E, Thompson JW, Rifas-Shiman SL, Vilchuk K, Bogdanovich N, Hameza M et al (2021) Analysis of maternal prenatal weight and offspring cognition and behavior: results from the promotion of breastfeeding intervention trial (PROBIT) cohort. JAMA Netw Open 4:e2121429","journal-title":"JAMA Netw Open"},{"key":"2119_CR252","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/oby.21055","volume":"23","author":"X Ou","year":"2015","unstructured":"Ou X, Thakali KM, Shankar K, Andres A, Badger TM (2015) Maternal adiposity negatively influences infant brain white matter development. Obes Silver Spring Md 23:1047\u20131054","journal-title":"Obes Silver Spring Md"},{"key":"2119_CR253","first-page":"1995","volume":"43","author":"J Verdejo-Rom\u00e1n","year":"2019","unstructured":"Verdejo-Rom\u00e1n J, Bj\u00f6rnholm L, Muetzel RL, Torres-Esp\u00ednola FJ, Lieslehto J, Jaddoe V et al (2019) Maternal prepregnancy body mass index and offspring white matter microstructure: results from three birth cohorts. Int J Obes 2005 43:1995\u20132006","journal-title":"Int J Obes 2005"},{"key":"2119_CR254","first-page":"1931","volume":"40","author":"X Li","year":"2016","unstructured":"Li X, Andres A, Shankar K, Pivik RT, Glasier CM, Ramakrishnaiah RH et al (2016) Differences in brain functional connectivity at resting state in neonates born to healthy obese or normal-weight mothers. Int J Obes 2005 40:1931\u20131934","journal-title":"Int J Obes 2005"},{"key":"2119_CR255","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/oby.22908","volume":"28","author":"ALB Shapiro","year":"2020","unstructured":"Shapiro ALB, Moore BF, Sutton B, Wilkening G, Stence N, Dabelea D et al (2020) In utero exposure to maternal overweight or obesity is associated with altered offspring brain function in middle childhood. Obes Silver Spring Md 28:1718\u20131725","journal-title":"Obes Silver Spring Md"},{"key":"2119_CR256","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/jcpp.13301","volume":"62","author":"ME Norr","year":"2021","unstructured":"Norr ME, Hect JL, Lenniger CJ, Van den Heuvel M, Thomason ME (2021) An examination of maternal prenatal BMI and human fetal brain development. J Child Psychol Psychiatry 62:458\u2013469","journal-title":"J Child Psychol Psychiatry"},{"key":"2119_CR257","doi-asserted-by":"publisher","first-page":"19182","DOI":"10.1038\/s41598-021-98574-9","volume":"11","author":"O Rajasilta","year":"2021","unstructured":"Rajasilta O, H\u00e4kkinen S, Bj\u00f6rnsdotter M, Scheinin NM, Lehtola SJ, Saunavaara J et al (2021) Maternal pre-pregnancy BMI associates with neonate local and distal functional connectivity of the left superior frontal gyrus. Sci Rep 11:19182","journal-title":"Sci Rep"},{"key":"2119_CR258","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.bbi.2016.08.005","volume":"58","author":"AE Graf","year":"2016","unstructured":"Graf AE, Lallier SW, Waidyaratne G, Thompson MD, Tipple TE, Hester ME et al (2016) Maternal high fat diet exposure is associated with increased Hepcidin levels, decreased myelination, and neurobehavioral changes in male offspring. Brain Behav Immun 58:369\u2013378","journal-title":"Brain Behav Immun"},{"key":"2119_CR259","doi-asserted-by":"publisher","first-page":"100281","DOI":"10.1016\/j.bbih.2021.100281","volume":"15","author":"M Bordeleau","year":"2021","unstructured":"Bordeleau M, Fern\u00e1ndez de Coss\u00edo L, Lacabanne C, Savage JC, Vernoux N, Chakravarty M et al (2021) Maternal high-fat diet modifies Myelin organization, microglial interactions, and results in social memory and sensorimotor gating deficits in adolescent mouse offspring. Brain Behav Immun - Health 15:100281","journal-title":"Brain Behav Immun - Health"},{"key":"2119_CR260","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2147\/CMAR.S362678","volume":"15","author":"Y Tang","year":"2023","unstructured":"Tang Y, Gutmann DH (2023) Neurofibromatosis type 1-Associated optic pathway gliomas: current challenges and future prospects. Cancer Manag Res 15:667\u2013681","journal-title":"Cancer Manag Res"},{"key":"2119_CR261","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1007\/s00381-024-06430-8","volume":"40","author":"C Kotch","year":"2024","unstructured":"Kotch C, de Blank P, Gutmann DH, Fisher MJ (2024) Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions. Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 40:3241\u20133250","journal-title":"Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg"},{"key":"2119_CR262","doi-asserted-by":"crossref","unstructured":"Chatterjee J, Qi X, Mu R, Li X, Eligator T, Ouyang M et al (2025) Intestinal bacteroides drives glioma progression by regulating CD8\u2009+\u2009T cell tumor infiltration. Neuro-Oncol 30;27(6):1579\u20131593","DOI":"10.1093\/neuonc\/noaf024"},{"key":"2119_CR263","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1212\/WNL.0000000000003881","volume":"88","author":"J Mahdi","year":"2017","unstructured":"Mahdi J, Shah AC, Sato A, Morris SM, McKinstry RC, Listernick R et al (2017) A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1. Neurology 88:1584\u20131589","journal-title":"Neurology"},{"key":"2119_CR264","doi-asserted-by":"publisher","first-page":"e1052","DOI":"10.1212\/WNL.0000000000009458","volume":"95","author":"J Mahdi","year":"2020","unstructured":"Mahdi J, Goyal MS, Griffith J, Morris SM, Gutmann DH (2020) Nonoptic pathway tumors in children with neurofibromatosis type 1. Neurology 95:e1052\u2013e1059","journal-title":"Neurology"},{"key":"2119_CR265","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00401-022-02478-5","volume":"144","author":"C-HG Lucas","year":"2022","unstructured":"Lucas C-HG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN et al (2022) Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathol (Berl) 144:747\u2013765","journal-title":"Acta Neuropathol (Berl)"},{"key":"2119_CR266","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00401-022-02513-5","volume":"145","author":"PJ Cimino","year":"2023","unstructured":"Cimino PJ, Ketchum C, Turakulov R, Singh O, Abdullaev Z, Giannini C et al (2023) Expanded analysis of high-grade Astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. Acta Neuropathol (Berl) 145:71\u201382","journal-title":"Acta Neuropathol (Berl)"},{"key":"2119_CR267","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/neuonc\/noad033","volume":"25","author":"CG Romo","year":"2023","unstructured":"Romo CG, Piotrowski AF, Campian JL, Diarte J, Rodriguez FJ, Bale TA et al (2023) Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1. Neuro-Oncol 25:1474\u20131486","journal-title":"Neuro-Oncol"},{"key":"2119_CR268","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","volume":"31","author":"S Nagaraja","year":"2017","unstructured":"Nagaraja S, Vitanza NA, Woo PJ, Taylor KR, Liu F, Zhang L et al (2017) Transcriptional dependencies in diffuse intrinsic Pontine glioma. Cancer Cell 31:635\u2013652e6","journal-title":"Cancer Cell"},{"key":"2119_CR269","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.molcel.2019.08.030","volume":"76","author":"S Nagaraja","year":"2019","unstructured":"Nagaraja S, Quezada MA, Gillespie SM, Arzt M, Lennon JJ, Woo PJ et al (2019) Histone variant and cell context determine H3K27M reprogramming of the enhancer landscape and oncogenic state. Mol Cell 76:965\u2013980e12","journal-title":"Mol Cell"},{"key":"2119_CR270","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ccell.2021.01.005","volume":"39","author":"D Haag","year":"2021","unstructured":"Haag D, Mack N, Benites Goncalves da Silva P, Statz B, Clark J, Tanabe K et al (2021) H3.3-K27M drives neural stem cell-specific gliomagenesis in a human iPSC-derived model. Cancer Cell 39:407\u2013422e13","journal-title":"Cancer Cell"},{"key":"2119_CR271","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s40478-022-01428-2","volume":"10","author":"C Anastasaki","year":"2022","unstructured":"Anastasaki C, Chatterjee J, Cobb O, Sanapala S, Scheaffer SM, De Andrade Costa A et al (2022) Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling. Acta Neuropathol Commun 10:120","journal-title":"Acta Neuropathol Commun"},{"key":"2119_CR272","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ccr.2008.12.006","volume":"15","author":"S Alcantara Llaguno","year":"2009","unstructured":"Alcantara Llaguno S, Chen J, Kwon C-H, Jackson EL, Li Y, Burns DK et al (2009) Malignant Astrocytomas originate from neural stem\/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 15:45\u201356","journal-title":"Cancer Cell"},{"key":"2119_CR273","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1073\/pnas.1101657108","volume":"108","author":"M Monje","year":"2011","unstructured":"Monje M, Mitra SS, Freret ME, Raveh TB, Kim J, Masek M et al (2011) Hedgehog-responsive candidate cell of origin for diffuse intrinsic Pontine glioma. Proc Natl Acad Sci U S A 108:4453\u20134458","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2119_CR274","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ccell.2015.09.007","volume":"28","author":"SR Alcantara Llaguno","year":"2015","unstructured":"Alcantara Llaguno SR, Wang Z, Sun D, Chen J, Xu J, Kim E et al (2015) Adult Lineage-Restricted CNS progenitors specify distinct glioblastoma subtypes. Cancer Cell 28:429\u2013440","journal-title":"Cancer Cell"},{"key":"2119_CR275","doi-asserted-by":"publisher","first-page":"47206","DOI":"10.18632\/oncotarget.17589","volume":"8","author":"AC Solga","year":"2017","unstructured":"Solga AC, Toonen JA, Pan Y, Cimino PJ, Ma Y, Castillon GA et al (2017) The cell of origin dictates the Temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. Oncotarget 8:47206\u201347215 2017\/05\/20 ed","journal-title":"Oncotarget"},{"key":"2119_CR276","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.aao4750","volume":"360","author":"MG Filbin","year":"2018","unstructured":"Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND et al (2018) Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360:331\u2013335","journal-title":"Science"},{"key":"2119_CR277","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ et al (2019) An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178:835\u2013849e21","journal-title":"Cell"},{"key":"2119_CR278","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cell.2011.06.014","volume":"146","author":"C Liu","year":"2011","unstructured":"Liu C, Sage JC, Miller MR, Verhaak RGW, Hippenmeyer S, Vogel H et al (2011) Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 146:209\u2013221","journal-title":"Cell"},{"key":"2119_CR279","doi-asserted-by":"publisher","first-page":"E4214","DOI":"10.1073\/pnas.1414389111","volume":"111","author":"RP Galvao","year":"2014","unstructured":"Galvao RP, Kasina A, McNeill RS, Harbin JE, Foreman O, Verhaak RGW et al (2014) Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process. Proc Natl Acad Sci 111:E4214\u2013E4223","journal-title":"Proc Natl Acad Sci"},{"key":"2119_CR280","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1158\/0008-5472.CAN-20-1037","volume":"81","author":"MD Sutcliffe","year":"2021","unstructured":"Sutcliffe MD, Galvao RP, Wang L, Kim J, Rosenfeld LK, Singh S et al (2021) Premalignant oligodendrocyte precursor cells stall in a heterogeneous state of replication stress prior to gliomagenesis. Cancer Res 81:1868\u20131882","journal-title":"Cancer Res"},{"key":"2119_CR281","doi-asserted-by":"crossref","unstructured":"Pan Y, Hysinger JD, Barron T, Schindler NF, Cobb O, Guo X et al (2021) NF1 mutation drives neuronal activity-dependent initiation of optic glioma. Nature. \/05\/28 ed. 2021;594:277\u201382","DOI":"10.1038\/s41586-021-03580-6"},{"key":"2119_CR282","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41586-022-04719-9","volume":"606","author":"P Chen","year":"2022","unstructured":"Chen P, Wang W, Liu R, Lyu J, Zhang L, Li B et al (2022) Olfactory sensory experience regulates gliomagenesis via neuronal IGF1. Nature 606:550\u2013556","journal-title":"Nature"},{"key":"2119_CR283","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3171\/jns.1961.18.4.0466","volume":"18","author":"SA Luse","year":"1961","unstructured":"Luse SA (1961) An electron microscopic study of normal optic nerve and of an optic-nerve glioma. J Neurosurg 18:466\u2013478","journal-title":"J Neurosurg"},{"key":"2119_CR284","first-page":"324","volume":"83","author":"DR Anderson","year":"1970","unstructured":"Anderson DR, Spencer WH (1970) Ultrastructural and histochemical observations of optic nerve gliomas. Arch Ophthalmol Chic Ill 1960 83:324\u2013335","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"2119_CR285","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0022-3476(94)70122-9","volume":"125","author":"R Listernick","year":"1994","unstructured":"Listernick R, Charrow J, Greenwald M, Mets M (1994) Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 125:63\u201366","journal-title":"J Pediatr"},{"key":"2119_CR286","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/NEN.0b013e3181a3240b","volume":"68","author":"B Hegedus","year":"2009","unstructured":"Hegedus B, Hughes FW, Garbow JR, Gianino S, Banerjee D, Kim K et al (2009) Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma. J Neuropathol Exp Neurol 68:542\u2013551","journal-title":"J Neuropathol Exp Neurol"},{"key":"2119_CR287","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/neuonc\/nos076","volume":"14","author":"MJ Fisher","year":"2012","unstructured":"Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ et al (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol 14:790\u2013797","journal-title":"Neuro Oncol"},{"key":"2119_CR288","doi-asserted-by":"crossref","unstructured":"Gibson EM, Monje M (2020) Treating cancer therapy-related cognitive impairment. Nat Med. 2020\/08\/01 ed. ;26:1174\u20135","DOI":"10.1038\/s41591-020-1014-1"},{"key":"2119_CR289","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/pbc.25896","volume":"63","author":"PMK de Blank","year":"2016","unstructured":"de Blank PMK, Berman JI, Fisher MJ (2016) Systemic chemotherapy and white matter integrity in tracts associated with cognition among children with neurofibromatosis type 1. Pediatr Blood Cancer 63:818\u2013824","journal-title":"Pediatr Blood Cancer"},{"key":"2119_CR290","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nrn.2017.136","volume":"18","author":"RJM Franklin","year":"2017","unstructured":"Franklin RJM, Ffrench-Constant C (2017) Regenerating CNS myelin - from mechanisms to experimental medicines. Nat Rev Neurosci 18:753\u2013769","journal-title":"Nat Rev Neurosci"},{"key":"2119_CR291","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41598-018-35734-4","volume":"9","author":"CR Hooijmans","year":"2019","unstructured":"Hooijmans CR, Hlavica M, Schuler FAF, Good N, Good A, Baumgartner L et al (2019) Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis. Sci Rep 9:822","journal-title":"Sci Rep"},{"key":"2119_CR292","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/glia.20441","volume":"55","author":"VE Miron","year":"2007","unstructured":"Miron VE, Rajasekharan S, Jarjour AA, Zamvil SS, Kennedy TE, Antel JP (2007) Simvastatin regulates oligodendroglial process dynamics and survival. Glia 55:130\u2013143","journal-title":"Glia"},{"key":"2119_CR293","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.2353\/ajpath.2009.080947","volume":"174","author":"VE Miron","year":"2009","unstructured":"Miron VE, Zehntner SP, Kuhlmann T, Ludwin SK, Owens T, Kennedy TE et al (2009) Statin therapy inhibits remyelination in the central nervous system. Am J Pathol 174:1880\u20131890","journal-title":"Am J Pathol"},{"key":"2119_CR294","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/glia.20769","volume":"57","author":"O Maier","year":"2009","unstructured":"Maier O, De Jonge J, Nomden A, Hoekstra D, Baron W (2009) Lovastatin induces the formation of abnormal myelin-like membrane sheets in primary oligodendrocytes. Glia 57:402\u2013413","journal-title":"Glia"},{"key":"2119_CR295","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jama.300.3.287","volume":"300","author":"LC Krab","year":"2008","unstructured":"Krab LC, de Goede-Bolder A, Aarsen FK, Pluijm SMF, Bouman MJ, van der Geest JN et al (2008) Effect of Simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA 300:287\u2013294","journal-title":"JAMA"},{"key":"2119_CR296","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S1474-4422(13)70227-8","volume":"12","author":"T van der Vaart","year":"2013","unstructured":"van der Vaart T, Plasschaert E, Rietman AB, Renard M, Oostenbrink R, Vogels A et al (2013) Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial. Lancet Neurol 12:1076\u20131083","journal-title":"Lancet Neurol"},{"key":"2119_CR297","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/acn3.288","volume":"3","author":"CE Bearden","year":"2016","unstructured":"Bearden CE, Hellemann GS, Rosser T, Montojo C, Jonas R, Enrique N et al (2016) A randomized placebo-controlled Lovastatin trial for neurobehavioral function in neurofibromatosis I. Ann Clin Transl Neurol 3:266\u2013279","journal-title":"Ann Clin Transl Neurol"},{"key":"2119_CR298","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1212\/WNL.0000000000003435","volume":"87","author":"JM Payne","year":"2016","unstructured":"Payne JM, Barton B, Ullrich NJ, Cantor A, Hearps SJC, Cutter G et al (2016) Randomized placebo-controlled study of Lovastatin in children with neurofibromatosis type 1. Neurology 87:2575\u20132584","journal-title":"Neurology"},{"key":"2119_CR299","first-page":"1556","volume":"10","author":"AP Agouridis","year":"2023","unstructured":"Agouridis AP, Palli N, Karagiorga V-E, Konsoula A, Markaki L, Spernovasilis N et al (2023) Statins in children with neurofibromatosis type 1: A systematic review of randomized controlled trials. Child Basel Switz 10:1556","journal-title":"Child Basel Switz"},{"key":"2119_CR300","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/neuonc\/noac165","volume":"24","author":"PMK de Blank","year":"2022","unstructured":"de Blank PMK, Gross AM, Akshintala S, Blakeley JO, Bollag G, Cannon A et al (2022) MEK inhibitors for neurofibromatosis type 1 manifestations: clinical evidence and consensus. Neuro-Oncol 24:1845\u20131856","journal-title":"Neuro-Oncol"},{"key":"2119_CR301","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1038\/s41401-024-01313-9","volume":"45","author":"Y Yang","year":"2024","unstructured":"Yang Y, Suo N, Cui S-H, Wu X, Ren X-Y, Liu Y et al (2024) Trametinib, an anti-tumor drug, promotes oligodendrocytes generation and Myelin formation. Acta Pharmacol Sin 45:2527\u20132539","journal-title":"Acta Pharmacol Sin"},{"key":"2119_CR302","doi-asserted-by":"publisher","first-page":"e616","DOI":"10.1212\/NXG.0000000000000616","volume":"7","author":"KS Walsh","year":"2021","unstructured":"Walsh KS, Wolters PL, Widemann BC, Del Castillo A, Sady MD, Inker T et al (2021) Impact of MEK inhibitor therapy on neurocognitive functioning in NF1. Neurol Genet 7:e616","journal-title":"Neurol Genet"},{"key":"2119_CR303","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s11060-024-04624-3","volume":"167","author":"E Lalancette","year":"2024","unstructured":"Lalancette E, Cantin \u00c9, Routhier M-\u00c8, Mailloux C, Bertrand M-C, Kiaei DS et al (2024) Impact of Trametinib on the neuropsychological profile of NF1 patients. J Neurooncol 167:447\u2013454","journal-title":"J Neurooncol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02119-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02119-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02119-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:03:47Z","timestamp":1759154627000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02119-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":303,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2119"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02119-4","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}